ATB THERAPEUTICS

{
  "events": [
    {
      "kind": "capital_increase",
      "after_eur": 43763798.16,
      "delta_eur": 22357102.5,
      "before_eur": 21406695.66,
      "share_emission": {
        "agio_eur": null,
        "share_form": "no_nominal_value",
        "share_class": "A",
        "n_new_shares": 1682250,
        "with_new_shares": true,
        "nominal_value_eur": null,
        "issue_price_per_share_eur": 13.29
      },
      "decrease_purpose": null,
      "contribution_type": "geld",
      "paid_up_delta_eur": 22357102.5,
      "n_shares_destroyed": null,
      "not_yet_called_eur": null,
      "merger_new_shares_n": null,
      "merger_exchange_ratio": null,
      "distribution_amount_eur": null,
      "statutory_unavailable_equity_op": null
    }
  ],
  "notary": {
    "name": "Peter VAN MELKEBEKE",
    "firm_city": null,
    "firm_name": "BERQUIN NOTARISSEN",
    "office_city": "Brussel",
    "is_associated": true
  },
  "act_meta": {
    "language": "nl",
    "pub_date": "2026-04-13",
    "filing_date": "2026-04-09",
    "act_kind_objet": "Objet de l\u0027acte:"
  },
  "decision": {
    "body": "buitengewone_algemene_vergadering",
    "act_date": "2026-03-31",
    "unanimous": null,
    "under_authorized_capital": true,
    "underlying_resolution_date": null
  },
  "bedrijfsrevisor": null,
  "subject_company": {
    "kbo": "0677.980.015",
    "name_full": "ATB THERAPEUTICS",
    "legal_form": "Soci\u00E9t\u00E9 anonyme",
    "is_foreign_registered": false
  },
  "publication_proxy": {
    "kind": "none",
    "org_kbo": null,
    "org_name": null,
    "person_name": null,
    "org_rep_person_name": null,
    "person_role_at_subject": null
  },
  "co_filed_documents": [
    "expedition",
    "plan financier",
    "bankattest",
    "verslag bedrijfsrevisor"
  ],
  "shareholders_after": [],
  "share_classes_after": [
    {
      "n_shares": 3786914,
      "class_name": "A",
      "capital_share_eur": 43763798.16,
      "voting_rights_per_share": 1.0
    }
  ]
}

{
  "events": [
    {
      "kind": "capital_increase",
      "after_eur": 43763798.16,
      "delta_eur": 22357102.5,
      "before_eur": 21406695.66,
      "share_emission": {
        "agio_eur": null,
        "share_form": "no_nominal_value",
        "share_class": "Series A",
        "n_new_shares": 1682250,
        "with_new_shares": true,
        "nominal_value_eur": null,
        "issue_price_per_share_eur": 13.29
      },
      "decrease_purpose": null,
      "contribution_type": "numeraire",
      "paid_up_delta_eur": 22357102.5,
      "n_shares_destroyed": null,
      "not_yet_called_eur": null,
      "merger_new_shares_n": null,
      "merger_exchange_ratio": null,
      "distribution_amount_eur": null,
      "statutory_unavailable_equity_op": null
    }
  ],
  "notary": {
    "name": "Peter VAN MELKEBEKE",
    "firm_city": null,
    "firm_name": "Berquin Notaires",
    "office_city": "Bruxelles",
    "is_associated": true
  },
  "act_meta": {
    "language": "fr",
    "pub_date": "2026-04-13",
    "filing_date": "2026-04-09",
    "act_kind_objet": "Objet de l\u0027acte:"
  },
  "decision": {
    "body": "assembl\u00E9e_generale_extraordinaire",
    "act_date": "2026-03-31",
    "unanimous": null,
    "under_authorized_capital": true,
    "underlying_resolution_date": null
  },
  "bedrijfsrevisor": null,
  "subject_company": {
    "kbo": "0677.980.015",
    "name_full": "ATB THERAPEUTICS",
    "legal_form": "Soci\u00E9t\u00E9 anonyme",
    "is_foreign_registered": false
  },
  "publication_proxy": {
    "kind": null,
    "org_kbo": null,
    "org_name": null,
    "person_name": null,
    "org_rep_person_name": null,
    "person_role_at_subject": null
  },
  "co_filed_documents": [
    "exp\u00E9dition du proc\u00E8s-verbal",
    "liste de pr\u00E9sences",
    "procurations",
    "texte coordonn\u00E9 des statuts",
    "rapport du conseil d\u2019administration",
    "rapport du commissaire"
  ],
  "shareholders_after": [],
  "share_classes_after": [
    {
      "n_shares": 3786914,
      "class_name": "Actions Series A",
      "capital_share_eur": 43763798.16,
      "voting_rights_per_share": 1.0
    }
  ]
}

{
  "notary": {
    "name": "Peter VAN MELKEBEKE",
    "firm_city": null,
    "firm_name": "BERQUIN NOTARISSEN",
    "office_city": "Brussel",
    "is_associated": true
  },
  "act_meta": {
    "language": "nl",
    "pub_date": "2026-04-13",
    "filing_date": "2026-04-09",
    "act_kind_objet": "CAPITAL, ACTIONS, STATUTS (TRADUCTION, COORDINATION, AUTRES MODIFICATIONS)"
  },
  "decision": {
    "body": "buitengewone_algemene_vergadering",
    "act_date": "2026-03-31",
    "unanimous": null
  },
  "statute_change": {
    "kinds": [
      "translation",
      "coordination",
      "full_restatement",
      "object_change"
    ],
    "scope": "full_restatement",
    "trigger": null,
    "language_after": "nl",
    "language_before": "nl"
  },
  "bedrijfsrevisor": null,
  "subject_company": {
    "kbo": "0677.980.015",
    "name_full_after": "ATB THERAPEUTICS",
    "legal_form_after": "naamloze vennootschap",
    "name_full_before": "ATB THERAPEUTICS",
    "current_zetel_raw": "Aye, Rue de la Science 8 6900 Marche-en-Famenne",
    "legal_form_before": "Soci\u00E9t\u00E9 anonyme"
  },
  "special_mandates": [
    {
      "holder_kbo": null,
      "holder_name": "meester Sammy Perel",
      "scope_categories": [
        "kbo",
        "btw"
      ],
      "with_substitution": true
    },
    {
      "holder_kbo": null,
      "holder_name": "meester Fr\u00E9d\u00E9rique Joos",
      "scope_categories": [
        "kbo",
        "btw"
      ],
      "with_substitution": true
    },
    {
      "holder_kbo": null,
      "holder_name": "iedere andere advocaat of medewerker van het kantoor \u201CCambrian\u201D",
      "scope_categories": [
        "kbo",
        "btw"
      ],
      "with_substitution": true
    }
  ],
  "articles_modified": [
    {
      "summary": "De vennootschap heeft de vorm van een naamloze vennootschap en draagt de naam \u0022ATB THERAPEUTICS\u0022.",
      "new_text": "De vennootschap heeft de vorm van een naamloze vennootschap.\nZij draagt de naam \u0022ATB THERAPEUTICS\u0022. Deze naam moet steeds worden voorafgegaan of\ngevolgd door de woorden \u0022naamloze vennootschap\u0022 of de afkorting \u0022NV\u0022.",
      "change_kind": "restated",
      "article_title": "RECHTSVORM - NAAM",
      "article_number": "1"
    },
    {
      "summary": "De zetel van de vennootschap is gevestigd in het Waalse Gewest en kan naar een andere plaats in Belgi\u00EB worden overgebracht.",
      "new_text": "De zetel van de vennootschap is gevestigd in het Waalse Gewest.\nDe vennootschap kan de zetel overbrengen naar een andere plaats in Belgi\u00EB overeenkomstig de\ntoepasselijke wetgeving.\nDe vennootschap kan, overeenkomstig artikel 16.2.5, zowel in Belgi\u00EB als in het buitenland\nbijkantoren, filialen en agentschappen oprichten.",
      "change_kind": "restated",
      "article_title": "ZETEL",
      "article_number": "2"
    },
    {
      "summary": "De vennootschap heeft tot voorwerp, zowel in Belgi\u00EB als in het buitenland, voor eigen rekening, voor rekening van derden of in samenwerking met derden: alle activiteiten in verband met fundamenteel of toegepast onderzoek, alsook de ontwikkeling van alle farmaceutische producten voor therapeutisch en",
      "new_text": "De vennootschap heeft tot voorwerp, zowel in Belgi\u00EB als in het buitenland, voor eigen rekening, voor\nrekening van derden of in samenwerking met derden:\n\u2022 alle activiteiten in verband met fundamenteel of toegepast onderzoek, alsook de\nontwikkeling van alle farmaceutische producten voor therapeutisch en/of diagnostisch gebruik;\n\u2022 de ontwikkeling, exploitatie en verkoop van producten of van alle lice",
      "change_kind": "restated",
      "article_title": "VOORWERP",
      "article_number": "3"
    },
    {
      "summary": "De vennootschap is opgericht voor onbepaalde tijd.",
      "new_text": "De vennootschap is opgericht voor onbepaalde tijd.",
      "change_kind": "restated",
      "article_title": "DUUR",
      "article_number": "4"
    },
    {
      "summary": "Het kapitaal van de vennootschap bedraagt EUR 43.763.798,16 en is verdeeld in 3.786.914 aandelen, elk \u00E9\u00E9n- drie miljoen zevenhonderd zesentachtigduizend negenhonderd veertiende (1/ 3. 786. 914e) van het kapitaal.",
      "new_text": "5.1 Bedrag van het kapitaal en aantal uitstaande aandelen\nHet kapitaal van de vennootschap bedraagt drie\u00EBnveertig miljoen zevenhonderd drie\u00EBnzestigduizend\n acht zevenhonderdnegentigeuro zestien cent (EUR 43.763. 798,16). Het is verdeeld in drie miljoen\nzevenhonderd zesentachtigduizend negenhonderdveertien ( 3. 786. 914) aandelen, zonder\nvermelding van nominale waarde, die elk \u00E9\u00E9n- drie miljoen zev",
      "change_kind": "restated",
      "article_title": "KAPITAAL",
      "article_number": "5"
    },
    {
      "summary": "De vennootschap wordt bestuurd door een raad van bestuur die bestaat uit maximaal acht bestuurders, benoemd op voorstel van de voorzitter, Belgische Investeerders, V-BIO/VIVES, EQT LS, MRLV en de aandeelhouders.",
      "new_text": "15.1 Samenstelling van de raad van bestuur\n15.1.1 De vennootschap wordt bestuurd door een raad van bestuur. De raad van bestuur bestaat\nuit maximaal acht (8) bestuurders, die als volgt worden benoemd:\n(i) De voorzitter van de raad van bestuur, die onafhankelijk zal zijn en over specifieke\nexpertise zal beschikken op het gebied van de bedrijfsactiviteiten van de vennootschap, wordt\nbenoemd op voors",
      "change_kind": "restated",
      "article_title": "SAMENSTELLING VAN DE RAAD VAN BESTUUR",
      "article_number": "15"
    },
    {
      "summary": "De raad van bestuur is bevoegd alle handelingen te verrichten die bijdragen tot de verwezenlijking van het doel van de vennootschap, met uitzondering van die welke de wet voorbehoudt aan de algemene vergadering en tenzij in deze statuten anders is bepaald.",
      "new_text": "De raad van bestuur is bevoegd alle handelingen te verrichten die bijdragen tot de verwezenlijking\nvan het doel van de vennootschap, met uitzondering van die welke de wet voorbehoudt aan de\nalgemene vergadering en tenzij in deze statuten anders is bepaald.",
      "change_kind": "restated",
      "article_title": "BEVOEGDHEDEN VAN DE RAAD",
      "article_number": "18"
    },
    {
      "summary": "De raad van bestuur kan het dagelijks bestuur en de vertegenwoordiging daarvan toevertrouwen aan \u00E9\u00E9n of meer bestuurders die hetzij alleen, hetzij met z\u2019n twee\u00EBn, hetzij gezamenlijk optreden, of aan \u00E9\u00E9n of meer bestuurders en andere leidinggevenden.",
      "new_text": "De raad van bestuur kan het dagelijks bestuur van de vennootschap in de zin van artikel 7:121 WVV,\nalsmede de vertegenwoordiging van dit dagelijks bestuur, toevertrouwen aan \u00E9\u00E9n of meer\nbestuurders die hetzij alleen, hetzij met z\u2019n twee\u00EBn, hetzij gezamenlijk optreden en die dan de titel\ndragen van personen die zijn aangewezen voor het dagelijks bestuur van de vennootschap, of aan\ne\u00E9n of meer bestu",
      "change_kind": "restated",
      "article_title": "DAGELIJKS BESTUUR - DELEGATIES",
      "article_number": "19"
    },
    {
      "summary": "Onverminderd de algemene vertegenwoordigingsbevoegdheid van de raad van bestuur wordt de vennootschap bij alle handelingen (met inbegrip van vertegenwoordiging in rechte) geldig vertegenwoordigd door (i) twee (2) bestuurders die gezamenlijk optreden, (ii) de personen die in het kader van het dagelij",
      "new_text": "Onverminderd de algemene vertegenwoordigingsbevoegdheid van de raad van bestuur wordt de\nvennootschap bij alle handelingen (met inbegrip van vertegenwoordiging in rechte) geldig\nvertegenwoordigd door (i) twee (2) bestuurders die gezamenlijk optreden, (ii) de personen die in het\nkader van het dagelijks bestuur van de vennootschap zijn aangewezen voor aangelegenheden\nbetreffende het dagelijks bestuu",
      "change_kind": "restated",
      "article_title": "VERTEGENWOORDIGING",
      "article_number": "20"
    },
    {
      "summary": "De algemene vergadering bestaat uit alle aandeelhouders die het recht hebben om zelf of via gevolmachtigden te stemmen, met inachtneming van de wettelijke en statutaire voorschriften.",
      "new_text": "De algemene vergadering bestaat uit alle aandeelhouders die het recht hebben om zelf of via\ngevolmachtigden te stemmen, met inachtneming van de wettelijke en statutaire voorschriften.\nDe besluiten die op regelmatige wijze door de algemene vergadering worden genomen, zijn bindend\nvoor alle aandeelhouders, ook voor de afwezigen of de tegenstemmers.",
      "change_kind": "restated",
      "article_title": "SAMENSTELLING EN BEVOEGDHEDEN",
      "article_number": "22"
    },
    {
      "summary": "De jaarlijkse algemene vergadering komt bijeen op de derde vrijdag van de maand juni om vijftien uur (Belgische tijd).",
      "new_text": "De jaarlijkse algemene vergadering komt bijeen op de derde vrijdag van de maand juni om vijftien\nuur (Belgische tijd).\nIndien het een wettelijke feestdag betreft, vindt de jaarlijkse algemene vergadering plaats op de\neerstvolgende werkdag. De vergadering kan buitengewoon worden bijeengeroepen telkens wanneer\nhet belang van de vennootschap dit vereist.\nZij moet worden bijeengeroepen op verzoek van ",
      "change_kind": "restated",
      "article_title": "VERGADERING",
      "article_number": "23"
    },
    {
      "summary": "De algemene vergaderingen worden gehouden op de zetel of op de plaats die in de oproeping is aangegeven, op initiatief van de raad van bestuur of de commissarissen.",
      "new_text": "De algemene vergaderingen worden gehouden op de zetel of op de plaats die in de oproeping is\naangegeven, op initiatief van de raad van bestuur of de commissarissen.\n(\u2026)",
      "change_kind": "restated",
      "article_title": "BIJEENROEPINGEN",
      "article_number": "24"
    },
    {
      "summary": "Om tot de algemene vergadering te worden toegelaten, kan de raad van bestuur eisen dat de houders van aandelen op naam vijf werkdagen v\u00F3\u00F3r de voor de vergadering vastgestelde datum hun voornemen om aan de algemene vergadering deel te nemen, kenbaar maken.",
      "new_text": "Om tot de algemene vergadering te worden toegelaten, kan de raad van bestuur eisen dat de\nhouders van aandelen op naam vijf werkdagen v\u00F3\u00F3r de voor de vergadering vastgestelde datum hun\nvoornemen om aan de algemene vergadering deel te nemen, kenbaar maken.\n(\u2026)",
      "change_kind": "restated",
      "article_title": "TOEGANG TOT DE VERGADERING",
      "article_number": "25"
    },
    {
      "summary": "Elke aandeelhouder kan zich op de algemene vergadering laten vertegenwoordigen door een gevolmachtigde.",
      "new_text": "Elke aandeelhouder kan zich op de algemene vergadering laten vertegenwoordigen door een\ngevolmachtigde.\nDe raad van bestuur kan het formulier voor de volmachten vaststellen en eisen dat deze binnen een\ndoor hem vastgestelde termijn worden neergelegd op de door hem aangegeven plaats.\nMede-eigenaren van aandelen moeten zich elk door \u00E9\u00E9n en dezelfde persoon laten\nvertegenwoordigen. De uitoefening van",
      "change_kind": "restated",
      "article_title": "VERTEGENWOORDIGING",
      "article_number": "28"
    },
    {
      "summary": "Het boekjaar begint op 1 januari en eindigt op 31 december.",
      "new_text": "Het boekjaar begint op 1 januari en eindigt op 31 december.",
      "change_kind": "restated",
      "article_title": "BOEKJAAR",
      "article_number": "33"
    },
    {
      "summary": "De jaarlijkse algemene vergadering beslist over de jaarrekening.",
      "new_text": "De jaarlijkse algemene vergadering beslist over de jaarrekening.\nNa de goedkeuring van de jaarrekening beslist de algemene vergadering in een afzonderlijke\nstemming over het verlenen van kwijting aan de bestuurders en de commissarissen, indien deze zijn\nbenoemd. Deze kwijting is slechts geldig wanneer de jaarrekening geen weglatingen of onjuiste\nvermeldingen bevat die een beeld van de vennootschap",
      "change_kind": "restated",
      "article_title": "STEMMING OVER DE JAARREKENING",
      "article_number": "34"
    },
    {
      "summary": "De algemene vergadering reserveert jaarlijks ten minste een twintigste van de nettowinst voor de vorming van een reservefonds.",
      "new_text": "De algemene vergadering reserveert jaarlijks ten minste een twintigste van de nettowinst voor de\nvorming van een reservefonds. Deze reservering is niet langer verplicht wanneer het reservefonds\neen tiende van het kapitaal bereikt.\nDe bestemming van het saldo wordt vrij bepaald door de algemene vergadering, op voorstel van de\nraad van bestuur.\nEr mag echter geen uitkering plaatsvinden wanneer het n",
      "change_kind": "restated",
      "article_title": "UITKERING",
      "article_number": "35"
    },
    {
      "summary": "Wanneer het nettovermogen als gevolg van een verlies is gedaald tot minder dan de helft van het kapitaal, moet de raad van bestuur de algemene vergadering bijeenroepen voor een vergadering die moet plaatsvinden binnen twee maanden vanaf het moment waarop het verlies is vastgesteld of had moeten word",
      "new_text": "Wanneer het nettovermogen als gevolg van een verlies is gedaald tot minder dan de helft van het\nkapitaal, moet de raad van bestuur de algemene vergadering bijeenroepen voor een vergadering die\nmoet plaatsvinden binnen twee maanden vanaf het moment waarop het verlies is vastgesteld of had\nmoeten worden vastgesteld krachtens de bepalingen van de wet of de statuten, teneinde te beslissen\nd over de on",
      "change_kind": "restated",
      "article_title": "VROEGTIJDIGE ONTBINDING",
      "article_number": "37"
    },
    {
      "summary": "Tenzij de liquidatie in \u00E9\u00E9n akte plaatsvindt, wordt de liquidatie bij ontbinding van de vennootschap uitgevoerd door een of meer liquidateurs die door de algemene vergadering worden benoemd.",
      "new_text": "Tenzij de liquidatie in \u00E9\u00E9n akte plaatsvindt, wordt de liquidatie bij ontbinding van de vennootschap\nuitgevoerd door een of meer liquidateurs die door de algemene vergadering worden benoemd.\nDe algemene vergadering bepaalt de bevoegdheden en de eventuele vergoeding van de liquidateur\n(s).\nIn de gevallen waarin de wet voorziet, treden deze curator(en) pas in functie nadat de\nondernemingsrechtbank h",
      "change_kind": "restated",
      "article_title": "LIQUIDATIE",
      "article_number": "38"
    }
  ],
  "governance_change": {
    "organ_kind_after": "collegial",
    "organ_kind_before": "collegial",
    "admin_delegated_added": [
      {
        "name": "V-BIO/VIVES-bestuurder",
        "excluded_powers": []
      },
      {
        "name": "EQT LS-bestuurders",
        "excluded_powers": []
      },
      {
        "name": "Belgische investeerdersbestuurder",
        "excluded_powers": []
      },
      {
        "name": "V-BIO/VIVES-bestuurder",
        "excluded_powers": []
      }
    ],
    "representation_rule_after": "twee_gezamenlijk",
    "co_signature_threshold_eur": null,
    "representation_rule_before": null
  },
  "publication_proxy": {
    "kind": "person",
    "org_kbo": null,
    "org_name": null,
    "person_name": "Peter VAN MELKEBEKE",
    "org_rep_person_name": null
  },
  "co_filed_documents": [
    "een uitgifte van het proces-verbaal",
    "een aanwezigheidslijst",
    "vijftien volmachten",
    "de geco\u00F6rdineerde tekst van statuten",
    "het verslag van de raad van bestuur",
    "het verslag van de commissaris opgesteld overeenkomstig de artikelen 7:155 en 7:179 van het Belgische Wetboek van vennootschappen en verenigingen",
    "het verslag van de raad van bestuur en het verslag van de commissaris opgesteld overeenkomstig de artikelen 7:155 en 7:180 van het Belgisch Wetboek van Vennootschappen en Verenigingen"
  ],
  "shareholder_rights": null,
  "voorwerp_change_summary": "De vennootschap heeft tot voorwerp, zowel in Belgi\u00EB als in het buitenland, voor eigen rekening, voor rekening van derden of in samenwerking met derden: alle activiteiten in verband met fundamenteel of toegepast onderzoek, alsook de ontwikkeling van alle farmaceutische producten voor therapeutisch en/of diagnostisch gebruik; de ontwikkeling, exploitatie en verkoop van producten of van alle licenties op medische en farmaceutische producten, zowel voor therapeutisch als diagnostisch gebruik; de ont",
  "capital_structure_change": {
    "operations": [
      "capital_increase_cash",
      "share_class_creation"
    ],
    "split_ratio": null,
    "shares_after": 3786914,
    "shares_before": 3786914,
    "capital_after_eur": 43763798.16,
    "capital_before_eur": 21406695.66,
    "share_classes_after": [
      {
        "count": 1682250,
        "label": "Aandelen van Serie A",
        "rights_summary": "Deel in de winsten pro rata temporis vanaf de inschrijving.",
        "voting_per_share": null
      }
    ]
  },
  "coordinated_text_lineage": null
}

{
  "events": [
    {
      "kind": "capital_increase",
      "amount": 22357102.5,
      "currency": "EUR",
      "after_eur": 43763798.16,
      "delta_eur": 22357102.5,
      "before_eur": 21406695.66,
      "amount_type": "kapitaal_effectief",
      "effective_date": "2026-03-31",
      "evidence_quote": "L\u0027assembl\u00E9e d\u00E9cide d\u0027augmenter le capital de la Soci\u00E9t\u00E9 \u00E0 concurrence de EUR 22.357.102,50, pour le porter de EUR 21.406.695,66 \u00E0 EUR 43.763.798,16, par l\u2019\u00E9mission de 1.682.250 Actions Series A ... \u00E0 souscrire par un apport en num\u00E9raire",
      "contribution_type": "cash"
    }
  ],
  "schema": "v3.2",
  "act_meta": {
    "model_id": 36,
    "extractor": "constrained-core-35b"
  },
  "subject_company": {
    "kbo": "0677.980.015",
    "name_full": "ATB THERAPEUTICS",
    "legal_form": "SA"
  }
}

{
  "notary": {
    "name": "Yorik DESMYTTERE",
    "firm_city": null,
    "firm_name": "Berquin Notaires",
    "office_city": "Bruxelles",
    "is_associated": true
  },
  "act_meta": {
    "language": "fr",
    "pub_date": "2025-07-07",
    "filing_date": "2025-07-03",
    "act_kind_objet": "STATUTS (TRADUCTION, COORDINATION, AUTRES MODIFICATIONS), CAPITAL, ACTIONS"
  },
  "decision": {
    "body": "buitengewone_algemene_vergadering",
    "act_date": "2025-06-19",
    "unanimous": null
  },
  "statute_change": {
    "kinds": [
      "translation",
      "coordination",
      "targeted_amendment"
    ],
    "scope": "translation_only",
    "trigger": "wvv_adaptation",
    "language_after": "fr",
    "language_before": "fr"
  },
  "bedrijfsrevisor": {
    "firm_kbo": "0429.501.944",
    "firm_name": "PwC R\u00E9viseurs d\u2019Entreprises SRL",
    "ibr_number": null,
    "individual_name": "Patrick MORTROUX"
  },
  "subject_company": {
    "kbo": "0677.980.015",
    "name_full_after": "ATB THERAPEUTICS",
    "legal_form_after": "Soci\u00E9t\u00E9 anonyme",
    "name_full_before": "ATB THERAPEUTICS",
    "current_zetel_raw": "Aye, Rue de la Science 8 6900 Marche-en-Famenne",
    "legal_form_before": "Soci\u00E9t\u00E9 anonyme"
  },
  "special_mandates": [
    {
      "holder_kbo": null,
      "holder_name": "Cambrian",
      "scope_categories": [
        "kbo",
        "btw"
      ],
      "with_substitution": true
    }
  ],
  "articles_modified": [
    {
      "summary": "Correction of the capital amount and the number of shares in circulation following a rectification of a previous resolution.",
      "new_text": "ARTICLE 5 CAPITAL\n5.1 Montant du capital et nombre d\u0027actions en circulation\nLe capital de la Soci\u00E9t\u00E9 s\u0027\u00E9l\u00E8ve \u00E0 vingt millions six cent treize mille six cent nonante-cinq euros soixante-six cents (EUR 20.613.695,66). Il est divis\u00E9 en deux millions cent quatre mille six soixante-quatre (2.104.664) actions, sans d\u00E9signation de valeur nominale, repr\u00E9sentant chacun un-deux millions cent quatre mille si",
      "change_kind": "amended",
      "article_title": "CAPITAL",
      "article_number": "5"
    }
  ],
  "governance_change": {
    "organ_kind_after": null,
    "organ_kind_before": null,
    "admin_delegated_added": [
      {
        "name": "Sammy Perel",
        "excluded_powers": []
      },
      {
        "name": "Lotte Van Winckel",
        "excluded_powers": []
      },
      {
        "name": "Fr\u00E9d\u00E9rique Joos",
        "excluded_powers": []
      }
    ],
    "representation_rule_after": null,
    "co_signature_threshold_eur": null,
    "representation_rule_before": null
  },
  "publication_proxy": {
    "kind": "person",
    "org_kbo": null,
    "org_name": null,
    "person_name": "Yorik DESMYTTERE",
    "org_rep_person_name": null
  },
  "co_filed_documents": [
    "une exp\u00E9dition du proc\u00E8s-verbal",
    "le texte coordonn\u00E9 des statuts",
    "le rapport du conseil d\u0027administration",
    "le rapport du commissaire"
  ],
  "shareholder_rights": null,
  "voorwerp_change_summary": null,
  "capital_structure_change": {
    "operations": [
      "capital_increase_kind",
      "share_class_creation"
    ],
    "split_ratio": null,
    "shares_after": 2104664,
    "shares_before": null,
    "capital_after_eur": 20613695.66,
    "capital_before_eur": 16085740.8,
    "share_classes_after": [
      {
        "count": 677662,
        "label": "Actions Ordinaires",
        "rights_summary": "jouissant des m\u00EAmes droits et avantages que les Actions Series A",
        "voting_per_share": null
      },
      {
        "count": 1427002,
        "label": "Actions Series A",
        "rights_summary": "jouissant des m\u00EAmes droits et avantages que les Actions Ordinaires",
        "voting_per_share": null
      }
    ]
  },
  "coordinated_text_lineage": {
    "previous_ag_date": "2024-10-18",
    "previous_mb_reference": "24440855"
  }
}

{
  "events": [
    {
      "kind": "capital_increase",
      "after_eur": 20613695.66,
      "delta_eur": 4527954.86,
      "before_eur": 16085740.8,
      "share_emission": {
        "agio_eur": null,
        "share_form": "no_nominal_value",
        "share_class": null,
        "n_new_shares": 425869,
        "with_new_shares": true,
        "nominal_value_eur": null,
        "issue_price_per_share_eur": null
      },
      "decrease_purpose": null,
      "contribution_type": "inschrijvingsrechten_uitgifte",
      "paid_up_delta_eur": null,
      "n_shares_destroyed": null,
      "not_yet_called_eur": null,
      "merger_new_shares_n": null,
      "merger_exchange_ratio": null,
      "distribution_amount_eur": null,
      "statutory_unavailable_equity_op": null
    },
    {
      "kind": "share_class_creation",
      "after_eur": null,
      "delta_eur": null,
      "before_eur": null,
      "share_emission": {
        "agio_eur": null,
        "share_form": null,
        "share_class": null,
        "n_new_shares": null,
        "with_new_shares": false,
        "nominal_value_eur": null,
        "issue_price_per_share_eur": null
      },
      "decrease_purpose": null,
      "contribution_type": null,
      "paid_up_delta_eur": null,
      "n_shares_destroyed": null,
      "not_yet_called_eur": null,
      "merger_new_shares_n": null,
      "merger_exchange_ratio": null,
      "distribution_amount_eur": null,
      "statutory_unavailable_equity_op": null
    },
    {
      "kind": "share_class_creation",
      "after_eur": null,
      "delta_eur": null,
      "before_eur": null,
      "share_emission": {
        "agio_eur": null,
        "share_form": null,
        "share_class": null,
        "n_new_shares": null,
        "with_new_shares": false,
        "nominal_value_eur": null,
        "issue_price_per_share_eur": null
      },
      "decrease_purpose": null,
      "contribution_type": null,
      "paid_up_delta_eur": null,
      "n_shares_destroyed": null,
      "not_yet_called_eur": null,
      "merger_new_shares_n": null,
      "merger_exchange_ratio": null,
      "distribution_amount_eur": null,
      "statutory_unavailable_equity_op": null
    }
  ],
  "notary": {
    "name": "Yorik DESMYTTERE",
    "firm_city": null,
    "firm_name": "Berquin Notaires",
    "office_city": "Bruxelles",
    "is_associated": true
  },
  "act_meta": {
    "language": "mixed",
    "pub_date": "2025-07-07",
    "filing_date": "2025-07-03",
    "act_kind_objet": "Objet de l\u0027acte : STATUTS (TRADUCTION, COORDINATION, AUTRES MODIFICATIONS), CAPITAL, ACTIONS"
  },
  "decision": {
    "body": "assembl\u00E9e_generale_extraordinaire",
    "act_date": "2025-06-19",
    "unanimous": null,
    "under_authorized_capital": false,
    "underlying_resolution_date": "2024-10-18"
  },
  "bedrijfsrevisor": {
    "waived": false,
    "firm_kbo": "0429.501.944",
    "firm_name": "PwC R\u00E9viseurs d\u2019Entreprises SRL",
    "ibr_number": null,
    "mission_type": "apport_nature",
    "individual_name": "Patrick MORTROUX"
  },
  "subject_company": {
    "kbo": "0677.980.015",
    "name_full": "ATB THERAPEUTICS",
    "legal_form": "Soci\u00E9t\u00E9 anonyme",
    "is_foreign_registered": false
  },
  "publication_proxy": {
    "kind": "none",
    "org_kbo": null,
    "org_name": null,
    "person_name": null,
    "org_rep_person_name": null,
    "person_role_at_subject": null
  },
  "co_filed_documents": [
    "exp\u00E9dition du proc\u00E8s-verbal",
    "texte coordonn\u00E9 des statuts",
    "rapport du conseil d\u0027administration",
    "rapport du commissaire"
  ],
  "shareholders_after": [],
  "share_classes_after": [
    {
      "n_shares": 677662,
      "class_name": "Ordinaires",
      "capital_share_eur": null,
      "voting_rights_per_share": null
    },
    {
      "n_shares": 1427002,
      "class_name": "Series A",
      "capital_share_eur": null,
      "voting_rights_per_share": null
    }
  ]
}

{
  "schema": "v3.2",
  "act_meta": {
    "model_id": 36,
    "extractor": "constrained-core-35b"
  },
  "statute_change": {
    "name_change": false,
    "seat_change": false,
    "object_change": false,
    "effective_date": "2025-06-19",
    "legal_form_change": false
  },
  "bedrijfsrevisor": {
    "quote": "Le rapport du commissaire de la Soci\u00E9t\u00E9 en date du 18 juin 2025, \u00E9tabli par la soci\u00E9t\u00E9 \u00E0 responsabilit\u00E9 limit\u00E9e \u00AB PwC R\u00E9viseurs d\u2019Entreprises \u00BB, \u00E0 1831 Machelen, Culliganlaan 5, titulaire du num\u00E9ro d\u2019entreprise 0429.501.944, repr\u00E9sent\u00E9e par Patrick MORTROUX, r\u00E9viseur d\u2019entreprises... pour laquelle nous avons \u00E9t\u00E9 d\u00E9sign\u00E9s par lettre de mission du 17 septembre 2024.",
    "firm_kbo": "0429.501.944",
    "firm_name": "PwC R\u00E9viseurs d\u2019Entreprises SRL",
    "ibr_number": null,
    "individual_name": "Patrick Mortroux"
  },
  "subject_company": {
    "kbo": "0677.980.015",
    "name_full": "ATB THERAPEUTICS",
    "legal_form": "SA"
  },
  "signature_regime": null,
  "special_mandates": [
    {
      "quote": "L\u0027assembl\u00E9e conf\u00E8re tous pouvoirs \u00E0 ma\u00EEtre Sammy Perel, ma\u00EEtre Lotte Van Winckel, ma\u00EEtre Fr\u00E9d\u00E9rique Joos et tout autre avocat ou collaborateur du cabinet \u00AB Cambrian \u00BB... avec droit de substitution, afin d\u0027assurer les formalit\u00E9s aupr\u00E8s d\u0027un guichet d\u2019entreprise en vue d\u2019assurer l\u2019inscription/la modification des donn\u00E9es dans la Banque Carrefour des Entreprises et, le cas \u00E9ch\u00E9ant, aupr\u00E8s de l\u0027Administration de la Taxe sur la Valeur Ajout\u00E9e",
      "holder_kbo": null,
      "holder_name": "Cambrian",
      "scope_categories": [
        "KBO",
        "tax",
        "filing"
      ],
      "with_substitution": true
    }
  ],
  "governance_change": {
    "admin_delegated_added": []
  }
}

{
  "events": [
    {
      "kind": "capital_increase",
      "amount": 4527954.86,
      "currency": "EUR",
      "after_eur": 20613695.66,
      "delta_eur": 4527954.86,
      "before_eur": 16085740.8,
      "amount_type": "kapitaal_effectief",
      "effective_date": "2025-06-19",
      "evidence_quote": "L\u0027assembl\u00E9e d\u00E9cide d\u0027augmenter le capital de la Soci\u00E9t\u00E9 \u00E0 concurrence de quatre millions cinq cent vingt-sept mille neuf cent cinquante-quatre euros quatre-vingt-six cents (\u20AC 4.527.954,86), pour le porter de seize millions quatre-vingt-cinq mille sept cent quarante euros quatre-vingts cents (EUR 16.085.740,80) \u00E0 vingt millions six cent treize mille six cent nonante-cinq euros soixante-six cents (EUR 20.613.695,66), par l\u0027\u00E9mission de deux cent nonante-huit mille trois cent trente-six (298.336) Actions Series A et cent vingt-sept mille cinq cent trente-trois 127.533 Actions Ordinaires ... \u00E0 titre de r\u00E9mun\u00E9ration pour l\u0027apport de cr\u00E9ances",
      "contribution_type": "in_kind"
    }
  ],
  "schema": "v3.2",
  "act_meta": {
    "model_id": 36,
    "extractor": "constrained-core-35b"
  },
  "subject_company": {
    "kbo": "0677.980.015",
    "name_full": "ATB THERAPEUTICS",
    "legal_form": "SA"
  }
}

{
  "events": [
    {
      "kind": "decharge_granted",
      "role": "commissaris",
      "person": null,
      "reason": null,
      "subkind": null,
      "via_org": {
        "kbo": "0429.501.944",
        "name": "PwC R\u00E9viseurs d\u2019Entreprises",
        "address": "1831 Machelen, Culliganlaan 5",
        "country": "BE",
        "legal_form": "SRL"
      },
      "statutory": "statutair",
      "compensated": null,
      "effective_date": null,
      "evidence_quote": "L\u2019assembl\u00E9e dispense le pr\u00E9sident de la lecture des rapports suivants: le rapport du commissaire de la Soci\u00E9t\u00E9, \u00E9tabli conform\u00E9ment aux articles 7:155, 7:179 et 7:197 du Code belge des Soci\u00E9t\u00E9s et des Associations",
      "decharge_status": "granted",
      "mandate_duration": null,
      "rep_rotation_new_rep": null,
      "rep_rotation_old_rep": null,
      "effective_date_qualifier": null
    },
    {
      "kind": "director_out",
      "role": "administrateur_d\u00E9l\u00E9gu\u00E9",
      "person": {
        "rrn": null,
        "name": "MAGY Bertrand",
        "address": null,
        "birth_date": null,
        "profession": null,
        "birth_place": null
      },
      "reason": "de_plein_droit_dissolution",
      "subkind": null,
      "via_org": {
        "kbo": null,
        "name": "MAGMAN",
        "address": null,
        "country": null,
        "legal_form": "SRL"
      },
      "statutory": "statutair",
      "compensated": null,
      "effective_date": null,
      "evidence_quote": "L\u2019assembl\u00E9e d\u00E9cide d\u2019accepter la d\u00E9mission des administrateurs suivants : - la soci\u00E9t\u00E9 \u00E0 responsabilit\u00E9 limit\u00E9e \u00AB MAGMAN \u00BB, repr\u00E9sent\u00E9e par monsieur MAGY Bertrand;",
      "decharge_status": null,
      "mandate_duration": null,
      "rep_rotation_new_rep": null,
      "rep_rotation_old_rep": null,
      "effective_date_qualifier": null
    },
    {
      "kind": "director_out",
      "role": "administrateur_d\u00E9l\u00E9gu\u00E9",
      "person": {
        "rrn": null,
        "name": "DETRIXHE Pierre",
        "address": null,
        "birth_date": null,
        "profession": null,
        "birth_place": null
      },
      "reason": "de_plein_droit_dissolution",
      "subkind": null,
      "via_org": {
        "kbo": null,
        "name": "Capital \u0026 Croissance",
        "address": null,
        "country": null,
        "legal_form": "Soci\u00E9t\u00E9 coop\u00E9rative"
      },
      "statutory": "statutair",
      "compensated": null,
      "effective_date": null,
      "evidence_quote": "L\u2019assembl\u00E9e d\u00E9cide d\u2019accepter la d\u00E9mission des administrateurs suivants : - la soci\u00E9t\u00E9 coop\u00E9rative \u00AB Capital \u0026 Croissance \u00BB, repr\u00E9sent\u00E9e par monsieur DETRIXHE Pierre;",
      "decharge_status": null,
      "mandate_duration": null,
      "rep_rotation_new_rep": null,
      "rep_rotation_old_rep": null,
      "effective_date_qualifier": null
    },
    {
      "kind": "director_out",
      "role": "administrateur_d\u00E9l\u00E9gu\u00E9",
      "person": {
        "rrn": null,
        "name": "BRANDT Eric",
        "address": null,
        "birth_date": null,
        "profession": null,
        "birth_place": null
      },
      "reason": "de_plein_droit_dissolution",
      "subkind": null,
      "via_org": {
        "kbo": null,
        "name": "NOSHAQ PARTNERS",
        "address": null,
        "country": null,
        "legal_form": "SRL"
      },
      "statutory": "statutair",
      "compensated": null,
      "effective_date": null,
      "evidence_quote": "L\u2019assembl\u00E9e d\u00E9cide d\u2019accepter la d\u00E9mission des administrateurs suivants : - la soci\u00E9t\u00E9 \u00E0 responsabilit\u00E9 limit\u00E9e \u00AB NOSHAQ PARTNERS \u00BB, repr\u00E9sent\u00E9e par monsieur BRANDT Eric;",
      "decharge_status": null,
      "mandate_duration": null,
      "rep_rotation_new_rep": null,
      "rep_rotation_old_rep": null,
      "effective_date_qualifier": null
    },
    {
      "kind": "director_out",
      "role": "administrateur_d\u00E9l\u00E9gu\u00E9",
      "person": {
        "rrn": null,
        "name": "MAJOIE J\u00E9r\u00F4me",
        "address": null,
        "birth_date": null,
        "profession": null,
        "birth_place": null
      },
      "reason": "de_plein_droit_dissolution",
      "subkind": null,
      "via_org": {
        "kbo": null,
        "name": "Fondation Fournier Majoie pour l\u2019Innovation",
        "address": null,
        "country": null,
        "legal_form": "Fondation d\u2019utilit\u00E9 publique"
      },
      "statutory": "statutair",
      "compensated": null,
      "effective_date": null,
      "evidence_quote": "L\u2019assembl\u00E9e d\u00E9cide d\u2019accepter la d\u00E9mission des administrateurs suivants : - la fondation d\u2019utilit\u00E9 publique \u00AB Fondation Fournier Majoie pour l\u2019Innovation \u00BB, repr\u00E9sent\u00E9e par monsieur MAJOIE J\u00E9r\u00F4me;",
      "decharge_status": null,
      "mandate_duration": null,
      "rep_rotation_new_rep": null,
      "rep_rotation_old_rep": null,
      "effective_date_qualifier": null
    },
    {
      "kind": "director_out",
      "role": "administrateur_d\u00E9l\u00E9gu\u00E9",
      "person": {
        "rrn": null,
        "name": "CAUTREELS Werner",
        "address": null,
        "birth_date": null,
        "profession": null,
        "birth_place": null
      },
      "reason": "de_plein_droit_dissolution",
      "subkind": null,
      "via_org": null,
      "statutory": "statutair",
      "compensated": null,
      "effective_date": null,
      "evidence_quote": "L\u2019assembl\u00E9e d\u00E9cide d\u2019accepter la d\u00E9mission des administrateurs suivants : - monsieur CAUTREELS Werner.",
      "decharge_status": null,
      "mandate_duration": null,
      "rep_rotation_new_rep": null,
      "rep_rotation_old_rep": null,
      "effective_date_qualifier": null
    },
    {
      "kind": "director_in",
      "role": "administrateur_d\u00E9l\u00E9gu\u00E9",
      "person": {
        "rrn": null,
        "name": "THROSBY Mark",
        "address": null,
        "birth_date": null,
        "profession": null,
        "birth_place": null
      },
      "reason": null,
      "subkind": null,
      "via_org": {
        "kbo": null,
        "name": "CHITON ROCKS",
        "address": "Kloveniersburgwal 103 2V, Amsterdam",
        "country": "NL",
        "legal_form": "soci\u00E9t\u00E9 selon le droit du Pays-Bas"
      },
      "statutory": "statutair",
      "compensated": null,
      "effective_date": null,
      "evidence_quote": "L\u2019assembl\u00E9e d\u00E9cide ensuite de nommer en tant qu\u2019administrateurs de la Soci\u00E9t\u00E9, avec effet imm\u00E9diat: - la soci\u00E9t\u00E9 selon le droit du Pays-Bas \u00AB CHITON ROCKS \u00BB, ayant son si\u00E8ge \u00E0 Kloveniersburgwal 103 2V, Amsterdam, Pays-Bas, repr\u00E9sent\u00E9e par THROSBY Mark (le Pr\u00E9sident);",
      "decharge_status": null,
      "mandate_duration": {
        "kind": "until_agm_year",
        "value": "2030"
      },
      "rep_rotation_new_rep": null,
      "rep_rotation_old_rep": null,
      "effective_date_qualifier": "immediate"
    },
    {
      "kind": "director_in",
      "role": "administrateur_d\u00E9l\u00E9gu\u00E9",
      "person": {
        "rrn": null,
        "name": "MAGY Bertrand",
        "address": null,
        "birth_date": null,
        "profession": null,
        "birth_place": null
      },
      "reason": null,
      "subkind": null,
      "via_org": {
        "kbo": null,
        "name": "MAGMAN",
        "address": "Rue aux Ruwales 2, 5024 Marche-les-Dames",
        "country": "BE",
        "legal_form": "SRL"
      },
      "statutory": "statutair",
      "compensated": null,
      "effective_date": null,
      "evidence_quote": "L\u2019assembl\u00E9e d\u00E9cide ensuite de nommer en tant qu\u2019administrateurs de la Soci\u00E9t\u00E9, avec effet imm\u00E9diat: - la soci\u00E9t\u00E9 selon le droit du Pays-Bas \u00AB CHITON ROCKS \u00BB, ayant son si\u00E8ge \u00E0 Kloveniersburgwal 103 2V, Amsterdam, Pays-Bas, repr\u00E9sent\u00E9e par THROSBY Mark (le Pr\u00E9sident);",
      "decharge_status": null,
      "mandate_duration": {
        "kind": "until_agm_year",
        "value": "2030"
      },
      "rep_rotation_new_rep": null,
      "rep_rotation_old_rep": null,
      "effective_date_qualifier": "immediate"
    },
    {
      "kind": "director_in",
      "role": "administrateur_d\u00E9l\u00E9gu\u00E9",
      "person": {
        "rrn": null,
        "name": "DETRIXHE Pierre",
        "address": null,
        "birth_date": null,
        "profession": null,
        "birth_place": null
      },
      "reason": null,
      "subkind": null,
      "via_org": {
        "kbo": null,
        "name": "Capital \u0026 Croissance",
        "address": "Rue de la Plaine 11, 6900 Marche-en-Famenne (Marche)",
        "country": "BE",
        "legal_form": "Soci\u00E9t\u00E9 coop\u00E9rative"
      },
      "statutory": "statutair",
      "compensated": null,
      "effective_date": null,
      "evidence_quote": "L\u2019assembl\u00E9e d\u00E9cide ensuite de nommer en tant qu\u2019administrateurs de la Soci\u00E9t\u00E9, avec effet imm\u00E9diat: - la soci\u00E9t\u00E9 coop\u00E9rative \u00AB Capital \u0026 Croissance \u00BB, ayant son si\u00E8ge \u00E0 Rue de la Plaine 11, 6900 Marche-en-Famenne (Marche), repr\u00E9sent\u00E9e par monsieur DETRIXHE Pierre, nomm\u00E9 sur proposition des investiss",
      "decharge_status": null,
      "mandate_duration": {
        "kind": "until_agm_year",
        "value": "2030"
      },
      "rep_rotation_new_rep": null,
      "rep_rotation_old_rep": null,
      "effective_date_qualifier": "immediate"
    },
    {
      "kind": "director_in",
      "role": "administrateur_d\u00E9l\u00E9gu\u00E9",
      "person": {
        "rrn": null,
        "name": "BROEKAERT Willem",
        "address": null,
        "birth_date": null,
        "profession": null,
        "birth_place": null
      },
      "reason": null,
      "subkind": null,
      "via_org": {
        "kbo": null,
        "name": "V-Bio Fund 2",
        "address": null,
        "country": null,
        "legal_form": "soci\u00E9t\u00E9 anonyme"
      },
      "statutory": "statutair",
      "compensated": null,
      "effective_date": null,
      "evidence_quote": "L\u2019assembl\u00E9e d\u00E9cide ensuite de nommer en tant qu\u2019administrateurs de la Soci\u00E9t\u00E9, avec effet imm\u00E9diat: - Monsieur BROEKAERT Willem, nomm\u00E9 sur proposition de la soci\u00E9t\u00E9 anonyme \u00AB V-Bio Fund 2 \u00BB, et de la soci\u00E9t\u00E9 anonyme \u00AB Vives Inter-University Fund \u00BB, (l\u0027Administrateur V-BIO/VIVES);",
      "decharge_status": null,
      "mandate_duration": {
        "kind": "until_agm_year",
        "value": "2030"
      },
      "rep_rotation_new_rep": null,
      "rep_rotation_old_rep": null,
      "effective_date_qualifier": "immediate"
    },
    {
      "kind": "director_in",
      "role": "administrateur_d\u00E9l\u00E9gu\u00E9",
      "person": {
        "rrn": null,
        "name": "DE KONING John",
        "address": null,
        "birth_date": null,
        "profession": null,
        "birth_place": null
      },
      "reason": null,
      "subkind": null,
      "via_org": {
        "kbo": null,
        "name": "LSP 7 Co\u00F6peratief U.A.",
        "address": null,
        "country": "NL",
        "legal_form": "soci\u00E9t\u00E9 de droit n\u00E9erlandais"
      },
      "statutory": "statutair",
      "compensated": null,
      "effective_date": null,
      "evidence_quote": "L\u2019assembl\u00E9e d\u00E9cide ensuite de nommer en tant qu\u2019administrateurs de la Soci\u00E9t\u00E9, avec effet imm\u00E9diat: - Monsieur DE KONING John, nomm\u00E9 sur proposition de la soci\u00E9t\u00E9 de droit n\u00E9erlandais \u00AB LSP 7 Co\u00F6peratief U.A. \u00BB, (l\u0027Administrateur EQT LS);",
      "decharge_status": null,
      "mandate_duration": {
        "kind": "until_agm_year",
        "value": "2030"
      },
      "rep_rotation_new_rep": null,
      "rep_rotation_old_rep": null,
      "effective_date_qualifier": "immediate"
    },
    {
      "kind": "director_in",
      "role": "administrateur_d\u00E9l\u00E9gu\u00E9",
      "person": {
        "rrn": null,
        "name": "BRICHARD Vincent",
        "address": null,
        "birth_date": null,
        "profession": null,
        "birth_place": null
      },
      "reason": null,
      "subkind": null,
      "via_org": {
        "kbo": null,
        "name": "LSP 7 Co\u00F6peratief U.A.",
        "address": null,
        "country": "NL",
        "legal_form": "soci\u00E9t\u00E9 de droit n\u00E9erlandais"
      },
      "statutory": "statutair",
      "compensated": null,
      "effective_date": null,
      "evidence_quote": "L\u2019assembl\u00E9e d\u00E9cide ensuite de nommer en tant qu\u2019administrateurs de la Soci\u00E9t\u00E9, avec effet imm\u00E9diat: - Monsieur BRICHARD Vincent, nomm\u00E9 sur proposition de la soci\u00E9t\u00E9 de droit n\u00E9erlandais \u00AB LSP 7 Co\u00F6peratief U.A. \u00BB, (l\u0027Administrateur EQT LS);",
      "decharge_status": null,
      "mandate_duration": {
        "kind": "until_agm_year",
        "value": "2030"
      },
      "rep_rotation_new_rep": null,
      "rep_rotation_old_rep": null,
      "effective_date_qualifier": "immediate"
    },
    {
      "kind": "director_in",
      "role": "administrateur_d\u00E9l\u00E9gu\u00E9",
      "person": {
        "rrn": null,
        "name": "KLEINHANS Karin",
        "address": null,
        "birth_date": null,
        "profession": null,
        "birth_place": null
      },
      "reason": null,
      "subkind": null,
      "via_org": {
        "kbo": null,
        "name": "MRL VENTURES FUND LLC",
        "address": null,
        "country": "US",
        "legal_form": "soci\u00E9t\u00E9 selon le droit de Delaware"
      },
      "statutory": "statutair",
      "compensated": null,
      "effective_date": null,
      "evidence_quote": "L\u2019assembl\u00E9e d\u00E9cide ensuite de nommer en tant qu\u2019administrateurs de la Soci\u00E9t\u00E9, avec effet imm\u00E9diat: - Madame KLEINHANS Karin, nomm\u00E9 sur proposition de la soci\u00E9t\u00E9 selon le droit de Delaware (\u00C9tats-Unis d\u2019Am\u00E9rique) \u00AB MRL VENTURES FUND LLC \u00BB, (l\u0027Administrateur MRLV);",
      "decharge_status": null,
      "mandate_duration": {
        "kind": "until_agm_year",
        "value": "2030"
      },
      "rep_rotation_new_rep": null,
      "rep_rotation_old_rep": null,
      "effective_date_qualifier": "immediate"
    },
    {
      "kind": "director_in",
      "role": "administrateur_d\u00E9l\u00E9gu\u00E9",
      "person": {
        "rrn": null,
        "name": "MAGY Bertrand",
        "address": null,
        "birth_date": null,
        "profession": null,
        "birth_place": null
      },
      "reason": null,
      "subkind": null,
      "via_org": {
        "kbo": null,
        "name": "MAGMAN",
        "address": "Rue aux Ruwales 2, 5024 Marche-les-Dames",
        "country": "BE",
        "legal_form": "SRL"
      },
      "statutory": "statutair",
      "compensated": null,
      "effective_date": null,
      "evidence_quote": "L\u2019assembl\u00E9e d\u00E9cide ensuite de nommer en tant qu\u2019administrateurs de la Soci\u00E9t\u00E9, avec effet imm\u00E9diat: - la soci\u00E9t\u00E9 \u00E0 responsabilit\u00E9 limit\u00E9e \u00AB MAGMAN \u00BB, ayant son si\u00E8ge \u00E0 Rue aux Ruwales 2, 5024 Marche-les-Dames, repr\u00E9sent\u00E9e par Monsieur MAGY Bertrand, nomm\u00E9 sur proposition des actionnaires de la Soci\u00E9",
      "decharge_status": null,
      "mandate_duration": {
        "kind": "until_agm_year",
        "value": "2030"
      },
      "rep_rotation_new_rep": null,
      "rep_rotation_old_rep": null,
      "effective_date_qualifier": "immediate"
    },
    {
      "kind": "decharge_granted",
      "role": "administrateur_d\u00E9l\u00E9gu\u00E9",
      "person": null,
      "reason": null,
      "subkind": null,
      "via_org": null,
      "statutory": "statutair",
      "compensated": null,
      "effective_date": null,
      "evidence_quote": "L\u0027assembl\u00E9e d\u00E9cide d\u0027accorder la d\u00E9charge provisoire aux administrateurs susmentionn\u00E9s pour l\u0027exercice de leurs fonctions d\u0027administrateurs depuis le d\u00E9but de l\u0027exercice en cours jusqu\u0027\u00E0 la date de leur d\u00E9mission.",
      "decharge_status": "provisional",
      "mandate_duration": null,
      "rep_rotation_new_rep": null,
      "rep_rotation_old_rep": null,
      "effective_date_qualifier": null
    },
    {
      "kind": "decharge_granted",
      "role": "administrateur_d\u00E9l\u00E9gu\u00E9",
      "person": null,
      "reason": null,
      "subkind": null,
      "via_org": null,
      "statutory": "statutair",
      "compensated": null,
      "effective_date": null,
      "evidence_quote": "La d\u00E9charge d\u00E9finitive pour la conduite de la des affaires de la Soci\u00E9t\u00E9 par les administrateurs sera accord\u00E9e lors de l\u0027approbation des comptes annuels de l\u0027exercice en cours.",
      "decharge_status": "pending_next_agm",
      "mandate_duration": null,
      "rep_rotation_new_rep": null,
      "rep_rotation_old_rep": null,
      "effective_date_qualifier": null
    }
  ],
  "notary": {
    "name": "Yorik DESMYTTERE",
    "firm_city": null,
    "firm_name": "Berquin Notaires",
    "office_city": "Bruxelles",
    "is_associated": true
  },
  "act_meta": {
    "language": "mixed",
    "pub_date": "2024-10-31",
    "filing_date": "2024-10-29",
    "act_kind_objet": "Objet de l\u0027acte:"
  },
  "decisions": [
    {
      "body": "algemene_vergadering",
      "date": "2024-10-18",
      "unanimous": null
    }
  ],
  "is_correction": false,
  "subject_company": {
    "kbo": "0677.980.015",
    "name_full": "ATB THERAPEUTICS",
    "legal_form": "SA"
  },
  "publication_proxy": {
    "kind": "person",
    "org_kbo": null,
    "org_name": null,
    "person_name": "Yorik DESMYTTERE",
    "org_rep_person_name": null,
    "person_role_at_subject": "Notaire"
  },
  "co_filed_documents": [
    "une exp\u00E9dition du proc\u00E8s-verbal",
    "vingt-sept procurations",
    "le rapport du conseil d\u2019administration \u00E9tabli en application des articles 7 :155 et 7 :180 du Code des soci\u00E9t\u00E9s et des associations",
    "le rapport du conseil d\u2019administration de la Soci\u00E9t\u00E9, \u00E9tabli conform\u00E9ment aux articles 7:155 et 7:179 du Code belge des Soci\u00E9t\u00E9s et des Associations",
    "le rapport du commissaire de la Soci\u00E9t\u00E9, \u00E9tabli conform\u00E9ment aux articles 7:155 et 7:179 du Code belge des Soci\u00E9t\u00E9s et des Associations",
    "le rapport du commissaire de la Soci\u00E9t\u00E9, \u00E9tabli conform\u00E9ment aux articles 7:155 et 7:180 du Code belge des Soci\u00E9t\u00E9s et des Associations",
    "le texte coordonn\u00E9 des statuts"
  ],
  "corrected_publication_numac": null
}

{
  "notary": {
    "name": "Yorik DESMYTTERE",
    "firm_city": null,
    "firm_name": "Berquin Notaires",
    "office_city": "Bruxelles",
    "is_associated": true
  },
  "act_meta": {
    "language": "fr",
    "pub_date": "2024-10-31",
    "filing_date": "2024-10-29",
    "act_kind_objet": "STATUTS (TRADUCTION, COORDINATION, AUTRES MODIFICATIONS), DEMISSIONS, NOMINATIONS, CAPITAL, ACTIONS"
  },
  "decision": {
    "body": "buitengewone_algemene_vergadering",
    "act_date": "2024-10-18",
    "unanimous": null
  },
  "statute_change": {
    "kinds": [
      "translation",
      "coordination",
      "full_restatement",
      "object_change",
      "share_split",
      "share_consolidation",
      "share_class_creation",
      "warrant_exercise_capital_update",
      "board_authorized_capital",
      "governance_restructure",
      "liquidation_preference_introduction",
      "seat_region_change"
    ],
    "scope": "full_restatement",
    "trigger": "wvv_adaptation",
    "language_after": "fr",
    "language_before": "fr"
  },
  "bedrijfsrevisor": {
    "firm_kbo": "0429.501.944",
    "firm_name": "PwC R\u00E9viseurs d\u2019Entreprises SRL",
    "ibr_number": null,
    "individual_name": "Patrick MORTROUX"
  },
  "subject_company": {
    "kbo": "0677.980.015",
    "name_full_after": "ATB THERAPEUTICS",
    "legal_form_after": "Soci\u00E9t\u00E9 anonyme",
    "name_full_before": "ATB THERAPEUTICS",
    "current_zetel_raw": "6900 Marche-en-Famenne (Aye), Rue de la Science 8",
    "legal_form_before": "Soci\u00E9t\u00E9 anonyme"
  },
  "special_mandates": [
    {
      "holder_kbo": null,
      "holder_name": "Baker McKenzie",
      "scope_categories": [
        "kbo",
        "ubo",
        "btw"
      ],
      "with_substitution": true
    }
  ],
  "articles_modified": [],
  "governance_change": {
    "organ_kind_after": "collegial",
    "organ_kind_before": "collegial",
    "admin_delegated_added": [
      {
        "name": "MAGMAN",
        "excluded_powers": []
      },
      {
        "name": "Capital \u0026 Croissance",
        "excluded_powers": []
      },
      {
        "name": "NOSHAQ PARTNERS",
        "excluded_powers": []
      },
      {
        "name": "Fondation Fournier Majoie pour l\u2019Innovation",
        "excluded_powers": []
      },
      {
        "name": "CAUTREELS Werner",
        "excluded_powers": []
      },
      {
        "name": "CHITON ROCKS",
        "excluded_powers": []
      },
      {
        "name": "Capital \u0026 Croissance",
        "excluded_powers": []
      },
      {
        "name": "BROEKAERT Willem",
        "excluded_powers": []
      },
      {
        "name": "DE KONING John",
        "excluded_powers": []
      },
      {
        "name": "BRICHARD Vincent",
        "excluded_powers": []
      },
      {
        "name": "KLEINHANS Karin",
        "excluded_powers": []
      },
      {
        "name": "MAGMAN",
        "excluded_powers": []
      }
    ],
    "representation_rule_after": "twee_gezamenlijk",
    "co_signature_threshold_eur": null,
    "representation_rule_before": null
  },
  "publication_proxy": {
    "kind": "person",
    "org_kbo": null,
    "org_name": null,
    "person_name": "Yorik DESMYTTERE",
    "org_rep_person_name": null
  },
  "co_filed_documents": [
    "une exp\u00E9dition du proc\u00E8s-verbal",
    "vingt-sept procurations",
    "le rapport du conseil d\u2019administration \u00E9tabli en application des articles 7 :155 et 7 :180 du Code des soci\u00E9t\u00E9s et des associations",
    "le rapport du conseil d\u2019administration de la Soci\u00E9t\u00E9, \u00E9tabli conform\u00E9ment aux articles 7:155 et 7:179 du Code belge des Soci\u00E9t\u00E9s et des Associations",
    "le rapport du commissaire de la Soci\u00E9t\u00E9, \u00E9tabli conform\u00E9ment aux articles 7:155 et 7:179 du Code belge des Soci\u00E9t\u00E9s et des Associations",
    "le rapport du commissaire de la Soci\u00E9t\u00E9, \u00E9tabli conform\u00E9ment aux articles 7:155 et 7:180 du Code belge des Soci\u00E9t\u00E9s et des Associations",
    "le texte coordonn\u00E9 des statuts"
  ],
  "shareholder_rights": {
    "quorum_rules_changed": false,
    "liquidation_preference_text": "En cas d\u0027\u00C9v\u00E9nement de Liquidation ou d\u0027\u00C9v\u00E9nement de Liquidation Pr\u00E9sum\u00E9e (et apr\u00E8s paiement de toutes les dettes et de tous les co\u00FBts encourus en rapport avec l\u0027\u00C9v\u00E9nement de Liquidation (Pr\u00E9sum\u00E9e) ou mise en r\u00E9serve de sommes suffisantes pour couvrir ces dettes et co\u00FBts), le produit net restant en num\u00E9raire, actions ou autres actifs, y compris, pour \u00E9viter toute ambigu\u00EFt\u00E9, tout paiement d\u0027option re\u00E7u en rapport avec l\u0027octroi d\u0027options sur tout actif dans le contexte d\u0027un \u00C9v\u00E9nement de Liquidation Pr\u00E9sum\u00E9e ou avant celui-ci) (le \u0022Produit de Liquidation\u0022) sera distribu\u00E9 comme suit: (i) Premi\u00E8rement, les Actionnaires Series A recevront, par pr\u00E9f\u00E9rence \u00E0 tout autre Actionnaire, un montant \u00E9gal \u00E0 une fois (1X) le Prix de Souscription Series A des Actions Series A qu\u0027ils d\u00E9tiennent (sous r\u00E9serve d\u0027un ajustement proportionnel en cas de division ou de regroupement d\u0027actions et d\u0027\u00E9v\u00E9nements similaires), augment\u00E9 du Dividende Accumul\u00E9 mais non pay\u00E9. Si le Produit de Liquidation est insuffisant pour payer int\u00E9gralement ce montant aux Actionnaires Series A, les montants disponibles seront pay\u00E9s au prorata entre les Actionnaires Series A (en tenant compte du Dividende Accumul\u00E9 mais non pay\u00E9 pour le calcul de ce prorata, le cas \u00E9ch\u00E9ant). Si le Produit de Liquidation consiste (en partie) en actions d\u0027une autre soci\u00E9t\u00E9 et que la SFPIM n\u0027est pas autoris\u00E9e \u00E0 accepter ces actions en vertu de ses statuts (ou d\u0027autres documents constitutifs, y compris sa charte ESG telle que modifi\u00E9e de temps \u00E0 autre) ou du droit applicable, ou (ii) parce que la soci\u00E9t\u00E9 sous-jacente ne satisfait pas aux exigences KYC de la SFPIM, les parties discuteront de bonne foi d\u0027une solution alternative pour la SFPIM, \u00E0 condition que cette discussion/solution n\u0027emp\u00EAche pas la Soci\u00E9t\u00E9 et les (autres) Actionnaires de r\u00E9aliser la transaction concern\u00E9e qui conduirait \u00E0 une telle distribution. (ii) Deuxi\u00E8mement, tout Produit de Liquidation restant sera distribu\u00E9 entre tous les Actionnaires (y compris les Actionnaires Se",
    "voorkeurrecht_rules_changed": false,
    "aandelenoverdracht_restrictions_changed": false
  },
  "voorwerp_change_summary": "La soci\u00E9t\u00E9 a pour objet, tant en Belgique qu\u0027\u00E0 l\u0027\u00E9tranger, pour compte propre, pour compte de tiers ou en participation avec des tiers : toutes activit\u00E9s li\u00E9es \u00E0 la recherche fondamentale ou appliqu\u00E9e ainsi que le d\u00E9veloppement de tous produits pharmaceutiques \u00E0 usage th\u00E9rapeutiques et/ou de diagnostiques ; tous services de recherche, d\u2019exp\u00E9rimentation et/ou de consultance \u00E0 destination de l\u0027industrie m\u00E9dicale, biotech et pharmaceutique, tous domaines confondus ; le d\u00E9veloppement, l\u2019exploitation",
  "capital_structure_change": {
    "operations": [
      "share_cancellation",
      "share_class_creation",
      "capital_increase_cash",
      "eigen_aandelen_inkoop",
      "eigen_aandelen_vernietigen",
      "wvv_capital_release"
    ],
    "split_ratio": null,
    "shares_after": 2104664,
    "shares_before": 524594,
    "capital_after_eur": 21406695.66,
    "capital_before_eur": 1085514.31,
    "share_classes_after": [
      {
        "count": 2104664,
        "label": "Actions Ordinaires",
        "rights_summary": "Droits et obligations tel que pr\u00E9cis\u00E9 au nouveau texte des statuts.",
        "voting_per_share": 1.0
      },
      {
        "count": 1128666,
        "label": "Actions Series A",
        "rights_summary": "Droits et avantages, y compris les dispositions relatives au vote multiple, les droits de dividende et les droits de pr\u00E9f\u00E9rence en cas de liquidation.",
        "voting_per_share": null
      },
      {
        "count": 298336,
        "label": "Actions de pr\u00E9f\u00E9rence de cat\u00E9gorie A",
        "rights_summary": "Sans d\u00E9signation de valeur nominale.",
        "voting_per_share": null
      }
    ]
  },
  "coordinated_text_lineage": null
}

{
  "events": [
    {
      "kind": "share_class_creation",
      "after_eur": null,
      "delta_eur": null,
      "before_eur": null,
      "decrease_purpose": null,
      "contribution_type": null,
      "paid_up_delta_eur": null,
      "n_shares_destroyed": null,
      "not_yet_called_eur": null,
      "merger_new_shares_n": null,
      "merger_exchange_ratio": null,
      "distribution_amount_eur": null,
      "statutory_unavailable_equity_op": null
    },
    {
      "kind": "share_class_creation",
      "after_eur": null,
      "delta_eur": null,
      "before_eur": null,
      "decrease_purpose": null,
      "contribution_type": null,
      "paid_up_delta_eur": null,
      "n_shares_destroyed": null,
      "not_yet_called_eur": null,
      "merger_new_shares_n": null,
      "merger_exchange_ratio": null,
      "distribution_amount_eur": null,
      "statutory_unavailable_equity_op": null
    },
    {
      "kind": "share_class_creation",
      "after_eur": null,
      "delta_eur": null,
      "before_eur": null,
      "decrease_purpose": null,
      "contribution_type": null,
      "paid_up_delta_eur": null,
      "n_shares_destroyed": null,
      "not_yet_called_eur": null,
      "merger_new_shares_n": null,
      "merger_exchange_ratio": null,
      "distribution_amount_eur": null,
      "statutory_unavailable_equity_op": null
    },
    {
      "kind": "capital_increase",
      "after_eur": 1085769.66,
      "delta_eur": 195.35,
      "before_eur": 1085574.31,
      "share_emission": {
        "agio_eur": null,
        "share_form": "no_nominal_value",
        "share_class": "Ordinaires",
        "n_new_shares": 19535,
        "with_new_shares": true,
        "nominal_value_eur": null,
        "issue_price_per_share_eur": 0.01
      },
      "decrease_purpose": null,
      "contribution_type": "geld",
      "paid_up_delta_eur": 195.35,
      "n_shares_destroyed": null,
      "not_yet_called_eur": null,
      "merger_new_shares_n": null,
      "merger_exchange_ratio": null,
      "distribution_amount_eur": null,
      "statutory_unavailable_equity_op": null
    },
    {
      "kind": "capital_increase",
      "after_eur": 16085740.8,
      "delta_eur": 14999971.14,
      "before_eur": 1085769.66,
      "share_emission": {
        "agio_eur": null,
        "share_form": "no_nominal_value",
        "share_class": "Series A",
        "n_new_shares": 1128666,
        "with_new_shares": true,
        "nominal_value_eur": null,
        "issue_price_per_share_eur": 13.29
      },
      "decrease_purpose": null,
      "contribution_type": "geld",
      "paid_up_delta_eur": 14999971.14,
      "n_shares_destroyed": null,
      "not_yet_called_eur": null,
      "merger_new_shares_n": null,
      "merger_exchange_ratio": null,
      "distribution_amount_eur": null,
      "statutory_unavailable_equity_op": null
    },
    {
      "kind": "capital_increase",
      "after_eur": 21406695.66,
      "delta_eur": 5320954.86,
      "before_eur": 16085740.8,
      "share_emission": {
        "agio_eur": null,
        "share_form": "no_nominal_value",
        "share_class": "Series A",
        "n_new_shares": 298336,
        "with_new_shares": true,
        "nominal_value_eur": null,
        "issue_price_per_share_eur": 13.29
      },
      "decrease_purpose": null,
      "contribution_type": "geld",
      "paid_up_delta_eur": 5320954.86,
      "n_shares_destroyed": null,
      "not_yet_called_eur": null,
      "merger_new_shares_n": null,
      "merger_exchange_ratio": null,
      "distribution_amount_eur": null,
      "statutory_unavailable_equity_op": null
    },
    {
      "kind": "capital_increase",
      "after_eur": null,
      "delta_eur": null,
      "before_eur": 21406695.66,
      "share_emission": {
        "agio_eur": null,
        "share_form": null,
        "share_class": "Ordinaires",
        "n_new_shares": null,
        "with_new_shares": true,
        "nominal_value_eur": null,
        "issue_price_per_share_eur": null
      },
      "decrease_purpose": null,
      "contribution_type": "geld",
      "paid_up_delta_eur": null,
      "n_shares_destroyed": null,
      "not_yet_called_eur": null,
      "merger_new_shares_n": null,
      "merger_exchange_ratio": null,
      "distribution_amount_eur": null,
      "statutory_unavailable_equity_op": null
    },
    {
      "kind": "other",
      "after_eur": null,
      "delta_eur": null,
      "before_eur": null,
      "_demoted_from": "capital_increase",
      "share_emission": {
        "agio_eur": null,
        "share_form": null,
        "share_class": null,
        "n_new_shares": null,
        "with_new_shares": true,
        "nominal_value_eur": null,
        "issue_price_per_share_eur": null
      },
      "decrease_purpose": null,
      "contribution_type": "geld",
      "paid_up_delta_eur": null,
      "n_shares_destroyed": null,
      "not_yet_called_eur": null,
      "merger_new_shares_n": null,
      "merger_exchange_ratio": null,
      "distribution_amount_eur": null,
      "statutory_unavailable_equity_op": null
    },
    {
      "kind": "other",
      "after_eur": null,
      "delta_eur": null,
      "before_eur": null,
      "_demoted_from": "capital_increase",
      "share_emission": {
        "agio_eur": null,
        "share_form": null,
        "share_class": null,
        "n_new_shares": null,
        "with_new_shares": true,
        "nominal_value_eur": null,
        "issue_price_per_share_eur": null
      },
      "decrease_purpose": null,
      "contribution_type": "geld",
      "paid_up_delta_eur": null,
      "n_shares_destroyed": null,
      "not_yet_called_eur": null,
      "merger_new_shares_n": null,
      "merger_exchange_ratio": null,
      "distribution_amount_eur": null,
      "statutory_unavailable_equity_op": null
    },
    {
      "kind": "share_class_creation",
      "after_eur": null,
      "delta_eur": null,
      "before_eur": null,
      "decrease_purpose": null,
      "contribution_type": null,
      "paid_up_delta_eur": null,
      "n_shares_destroyed": null,
      "not_yet_called_eur": null,
      "merger_new_shares_n": null,
      "merger_exchange_ratio": null,
      "distribution_amount_eur": null,
      "statutory_unavailable_equity_op": null
    }
  ],
  "notary": {
    "name": "Yorik DESMYTTERE",
    "firm_city": null,
    "firm_name": "Berquin Notaires",
    "office_city": "Bruxelles",
    "is_associated": true
  },
  "act_meta": {
    "language": "mixed",
    "pub_date": "2024-10-31",
    "filing_date": "2024-10-29",
    "act_kind_objet": "Objet de l\u0027acte:"
  },
  "decision": {
    "body": "assembl\u00E9e_generale_extraordinaire",
    "act_date": "2024-10-18",
    "unanimous": null,
    "under_authorized_capital": false,
    "underlying_resolution_date": null
  },
  "bedrijfsrevisor": {
    "waived": false,
    "firm_kbo": "0429.501.944",
    "firm_name": "PwC R\u00E9viseurs d\u2019Entreprises SRL",
    "ibr_number": null,
    "mission_type": "apport_nature",
    "individual_name": "Patrick MORTROUX"
  },
  "subject_company": {
    "kbo": "0677.980.015",
    "name_full": "ATB THERAPEUTICS",
    "legal_form": "Soci\u00E9t\u00E9 anonyme",
    "is_foreign_registered": true
  },
  "publication_proxy": {
    "kind": "person",
    "org_kbo": null,
    "org_name": null,
    "person_name": "Yorik DESMYTTERE",
    "org_rep_person_name": null,
    "person_role_at_subject": "notaire"
  },
  "co_filed_documents": [
    "exp\u00E9dition du proc\u00E8s-verbal",
    "procurations",
    "rapport du conseil d\u2019administration",
    "rapport du commissaire de la Soci\u00E9t\u00E9",
    "texte coordonn\u00E9 des statuts"
  ],
  "shareholders_after": [],
  "share_classes_after": [
    {
      "n_shares": 2104664,
      "class_name": "Ordinaires",
      "capital_share_eur": null,
      "voting_rights_per_share": 1.0
    },
    {
      "n_shares": null,
      "class_name": "Series A",
      "capital_share_eur": null,
      "voting_rights_per_share": null
    }
  ]
}

{
  "events": [
    {
      "kind": "director_out",
      "role": "bestuurder",
      "person": {
        "rrn": null,
        "name": "MAGY Bertrand",
        "address": null,
        "birth_date": null
      },
      "via_org": {
        "kbo": null,
        "name": "MAGMAN",
        "address": null,
        "country": null,
        "legal_form": null
      },
      "evidence_quote": "L\u2019assembl\u00E9e d\u00E9cide d\u2019accepter la d\u00E9mission des administrateurs suivants : - la soci\u00E9t\u00E9 \u00E0 responsabilit\u00E9 limit\u00E9e \u00AB MAGMAN \u00BB, repr\u00E9sent\u00E9e par monsieur MAGY Bertrand;",
      "discharge_granted": true
    },
    {
      "kind": "director_out",
      "role": "bestuurder",
      "person": {
        "rrn": null,
        "name": "DETRIXHE Pierre",
        "address": null,
        "birth_date": null
      },
      "via_org": {
        "kbo": null,
        "name": "Capital \u0026 Croissance",
        "address": null,
        "country": null,
        "legal_form": null
      },
      "evidence_quote": "L\u2019assembl\u00E9e d\u00E9cide d\u2019accepter la d\u00E9mission des administrateurs suivants : - la soci\u00E9t\u00E9 coop\u00E9rative \u00AB Capital \u0026 Croissance \u00BB, repr\u00E9sent\u00E9e par monsieur DETRIXHE Pierre;",
      "discharge_granted": true
    },
    {
      "kind": "director_out",
      "role": "bestuurder",
      "person": {
        "rrn": null,
        "name": "BRANDT Eric",
        "address": null,
        "birth_date": null
      },
      "via_org": {
        "kbo": null,
        "name": "NOSHAQ PARTNERS",
        "address": null,
        "country": null,
        "legal_form": null
      },
      "evidence_quote": "L\u2019assembl\u00E9e d\u00E9cide d\u2019accepter la d\u00E9mission des administrateurs suivants : - la soci\u00E9t\u00E9 \u00E0 responsabilit\u00E9 limit\u00E9e \u00AB NOSHAQ PARTNERS \u00BB, repr\u00E9sent\u00E9e par monsieur BRANDT Eric;",
      "discharge_granted": true
    },
    {
      "kind": "director_out",
      "role": "bestuurder",
      "person": {
        "rrn": null,
        "name": "MAJOIE J\u00E9r\u00F4me",
        "address": null,
        "birth_date": null
      },
      "via_org": {
        "kbo": null,
        "name": "Fondation Fournier Majoie pour l\u2019Innovation",
        "address": null,
        "country": null,
        "legal_form": null
      },
      "evidence_quote": "L\u2019assembl\u00E9e d\u00E9cide d\u2019accepter la d\u00E9mission des administrateurs suivants : - la fondation d\u2019utilit\u00E9 publique \u00AB Fondation Fournier Majoie pour l\u2019Innovation \u00BB, repr\u00E9sent\u00E9e par monsieur MAJOIE J\u00E9r\u00F4me;",
      "discharge_granted": true
    },
    {
      "kind": "director_out",
      "role": "bestuurder",
      "person": {
        "rrn": null,
        "name": "CAUTREELS Werner",
        "address": null,
        "birth_date": null
      },
      "evidence_quote": "L\u2019assembl\u00E9e d\u00E9cide d\u2019accepter la d\u00E9mission des administrateurs suivants : ... - monsieur CAUTREELS Werner.",
      "discharge_granted": true
    },
    {
      "kind": "director_in",
      "role": "bestuurder",
      "person": {
        "rrn": null,
        "name": "THROSBY Mark",
        "address": null,
        "birth_date": null
      },
      "via_org": {
        "kbo": null,
        "name": "CHITON ROCKS",
        "address": null,
        "country": null,
        "legal_form": null
      },
      "evidence_quote": "L\u2019assembl\u00E9e d\u00E9cide ensuite de nommer en tant qu\u2019administrateurs de la Soci\u00E9t\u00E9, avec effet imm\u00E9diat: - la soci\u00E9t\u00E9 selon le droit du Pays-Bas \u00AB CHITON ROCKS \u00BB, ayant son si\u00E8ge \u00E0 Kloveniersburgwal 103 2V, Amsterdam, Pays-Bas, repr\u00E9sent\u00E9e par THROSBY Mark (le Pr\u00E9sident);"
    },
    {
      "kind": "director_in",
      "role": "bestuurder",
      "person": {
        "rrn": null,
        "name": "DETRIXHE Pierre",
        "address": null,
        "birth_date": null
      },
      "via_org": {
        "kbo": null,
        "name": "Capital \u0026 Croissance",
        "address": null,
        "country": null,
        "legal_form": null
      },
      "evidence_quote": "L\u2019assembl\u00E9e d\u00E9cide ensuite de nommer en tant qu\u2019administrateurs de la Soci\u00E9t\u00E9, avec effet imm\u00E9diat: - la soci\u00E9t\u00E9 coop\u00E9rative \u00AB Capital \u0026 Croissance \u00BB, ayant son si\u00E8ge \u00E0 Rue de la Plaine 11, 6900 Marche-en-Famenne (Marche), repr\u00E9sent\u00E9e par monsieur DETRIXHE Pierre, nomm\u00E9 sur proposition des investiss"
    },
    {
      "kind": "director_in",
      "role": "bestuurder",
      "person": {
        "rrn": null,
        "name": "BROEKAERT Willem",
        "address": null,
        "birth_date": null
      },
      "evidence_quote": "L\u2019assembl\u00E9e d\u00E9cide ensuite de nommer en tant qu\u2019administrateurs de la Soci\u00E9t\u00E9, avec effet imm\u00E9diat: ... - Monsieur BROEKAERT Willem, nomm\u00E9 sur proposition de la soci\u00E9t\u00E9 anonyme \u00AB V-Bio Fund 2 \u00BB, et de la soci\u00E9t\u00E9 anonyme \u00AB Vives Inter-University Fund \u00BB, (l\u0027Administrateur V-BIO/VIVES);"
    },
    {
      "kind": "director_in",
      "role": "bestuurder",
      "person": {
        "rrn": null,
        "name": "DE KONING John",
        "address": null,
        "birth_date": null
      },
      "evidence_quote": "L\u2019assembl\u00E9e d\u00E9cide ensuite de nommer en tant qu\u2019administrateurs de la Soci\u00E9t\u00E9, avec effet imm\u00E9diat: ... - Monsieur DE KONING John, nomm\u00E9 sur proposition de la soci\u00E9t\u00E9 de droit n\u00E9erlandais \u00AB LSP 7 Co\u00F6peratief U.A. \u00BB, (l\u0027Administrateur EQT LS);"
    },
    {
      "kind": "director_in",
      "role": "bestuurder",
      "person": {
        "rrn": null,
        "name": "BRICHARD Vincent",
        "address": null,
        "birth_date": null
      },
      "evidence_quote": "L\u2019assembl\u00E9e d\u00E9cide ensuite de nommer en tant qu\u2019administrateurs de la Soci\u00E9t\u00E9, avec effet imm\u00E9diat: ... - Monsieur BRICHARD Vincent, nomm\u00E9 sur proposition de la soci\u00E9t\u00E9 de droit n\u00E9erlandais \u00AB LSP 7 Co\u00F6peratief U.A. \u00BB, (l\u0027Administrateur EQT LS);"
    },
    {
      "kind": "director_in",
      "role": "bestuurder",
      "person": {
        "rrn": null,
        "name": "KLEINHANS Karin",
        "address": null,
        "birth_date": null
      },
      "evidence_quote": "L\u2019assembl\u00E9e d\u00E9cide ensuite de nommer en tant qu\u2019administrateurs de la Soci\u00E9t\u00E9, avec effet imm\u00E9diat: ... - Madame KLEINHANS Karin, nomm\u00E9 sur proposition de la soci\u00E9t\u00E9 selon le droit de Delaware (\u00C9tats-Unis d\u0027Am\u00E9rique) \u00AB MRL VENTURES FUND LLC \u00BB, (l\u0027Administrateur MRLV);"
    },
    {
      "kind": "director_in",
      "role": "gedelegeerd_bestuurder",
      "person": {
        "rrn": null,
        "name": "MAGY Bertrand",
        "address": null,
        "birth_date": null
      },
      "via_org": {
        "kbo": null,
        "name": "MAGMAN",
        "address": null,
        "country": null,
        "legal_form": null
      },
      "evidence_quote": "L\u2019assembl\u00E9e d\u00E9cide ensuite de nommer en tant qu\u2019administrateurs de la Soci\u00E9t\u00E9, avec effet imm\u00E9diat: ... - la soci\u00E9t\u00E9 \u00E0 responsabilit\u00E9 limit\u00E9e \u00AB MAGMAN \u00BB, ayant son si\u00E8ge \u00E0 Rue aux Ruwales 2, 5024 Marche-les-Dames, repr\u00E9sent\u00E9e par Monsieur MAGY Bertrand, nomm\u00E9 sur proposition des actionnaires de la S"
    }
  ],
  "schema": "v3.2",
  "act_meta": {
    "model_id": 36,
    "extractor": "constrained-core-35b"
  },
  "subject_company": {
    "kbo": "0677.980.015",
    "name_full": "ATB THERAPEUTICS",
    "legal_form": "SA"
  }
}

{
  "schema": "v3.2",
  "act_meta": {
    "model_id": 36,
    "extractor": "constrained-core-35b"
  },
  "statute_change": {
    "name_change": false,
    "seat_change": false,
    "object_change": true,
    "effective_date": "2024-10-18",
    "legal_form_change": false
  },
  "bedrijfsrevisor": {
    "quote": "le rapport du commissaire de la Soci\u00E9t\u00E9 ... \u00E9tabli par la soci\u00E9t\u00E9 \u00E0 responsabilit\u00E9 limit\u00E9e \u00AB PwC R\u00E9viseurs d\u2019Entreprises \u00BB, \u00E0 1831 Machelen, Culliganlaan 5, titulaire du num\u00E9ro d\u2019entreprise 0429.501.944, repr\u00E9sent\u00E9e par Patrick MORTROUX, r\u00E9viseur d\u2019entreprises",
    "firm_kbo": "0429.501.944",
    "firm_name": "PwC R\u00E9viseurs d\u2019Entreprises",
    "ibr_number": null,
    "individual_name": "Patrick Mortroux"
  },
  "subject_company": {
    "kbo": "0677.980.015",
    "name_full": "ATB THERAPEUTICS",
    "legal_form": "SA"
  },
  "signature_regime": "joint_two",
  "special_mandates": [
    {
      "quote": "L\u0027assembl\u00E9e conf\u00E8re tous pouvoirs \u00E0 ma\u00EEtre Younes Sebbarh, ma\u00EEtre Brian Gielen, ma\u00EEtre Jean de Limburg Stirum, ma\u00EEtre Elvin Lawson, ma\u00EEtre Tine Torfs, Marie Vandenbrande et Hymad Ghazal et tout autre avocat ou collaborateur du cabinet \u00AB Baker McKenzie \u00BB, qui tous, \u00E0 cet effet, \u00E9lisent domicile \u00E0 1210 Saint-Josse-ten-Noode, Avenue du Boulevard 21 bo\u00EEte 1, chacun agissant s\u00E9par\u00E9ment, ainsi qu\u2019\u00E0 leurs employ\u00E9s, pr\u00E9pos\u00E9s et mandataires, avec droit de substitution, afin d\u0027assurer les formalit\u00E9s aupr\u00E8s d\u0027un guichet d\u2019entreprise en vue d\u2019assurer l\u2019inscription/la modification des donn\u00E9es dans la Banque Carrefour des Entreprises et, le cas \u00E9ch\u00E9ant, aupr\u00E8s de l\u0027Administration de la Taxe sur la Valeur Ajout\u00E9e.",
      "holder_kbo": null,
      "holder_name": "Baker McKenzie",
      "scope_categories": [
        "KBO",
        "filing",
        "formalities"
      ],
      "with_substitution": true
    }
  ],
  "governance_change": {
    "admin_delegated_added": [
      {
        "name": "MAGY Bertrand",
        "quote": "la soci\u00E9t\u00E9 \u00E0 responsabilit\u00E9 limit\u00E9e \u00AB MAGMAN \u00BB, ayant son si\u00E8ge \u00E0 Rue aux Ruwales 2, 5024 Marche-les-Dames, repr\u00E9sent\u00E9e par Monsieur MAGY Bertrand, nomm\u00E9 sur proposition des actionnaires de la Soci\u00E9t\u00E9 et qui portera le titre d\u0027administrateur-d\u00E9l\u00E9gu\u00E9 de la Soci\u00E9t\u00E9 (CEO);",
        "excluded_powers": null
      }
    ]
  }
}

{
  "events": [
    {
      "kind": "capital_increase",
      "amount": 60.0,
      "currency": "EUR",
      "after_eur": 1085574.31,
      "delta_eur": 60.0,
      "before_eur": 1085514.31,
      "amount_type": "kapitaal_effectief",
      "effective_date": "2024-10-18",
      "evidence_quote": "L\u0027assembl\u00E9e d\u00E9cide d\u0027augmenter le capital de la Soci\u00E9t\u00E9 \u00E0 concurrence de soixante euros (EUR 60,00), pour le porter de un million quatre-vingt-cinq mille cinq cent quatorze euros trente et un cents (EUR 1.085.514,31) \u00E0 un million quatre-vingt-cinq mille cinq cent septante-quatre euros trente et un cents (EUR 1.085.574,31). L\u0027augmentation de capital sera r\u00E9alis\u00E9e par apport en num\u00E9raire",
      "contribution_type": "cash"
    },
    {
      "kind": "capital_increase",
      "amount": 195.35,
      "currency": "EUR",
      "after_eur": 1085769.66,
      "delta_eur": 195.35,
      "before_eur": 1085574.31,
      "amount_type": "kapitaal_effectief",
      "effective_date": "2024-10-18",
      "evidence_quote": "L\u0027assembl\u00E9e d\u00E9cide d\u0027augmenter le capital de la Soci\u00E9t\u00E9 \u00E0 concurrence de cent nonante-cinq euros et trente-cinq cents (EUR 195,35), pour le porter de un million quatre-vingt-cinq mille cinq cent septante-quatre euros trente et un cents (EUR 1.085.574,31) \u00E0 un million quatre-vingt-cinq mille sept cent soixante-neuf euros et soixante-six cents (EUR 1.085.769,66). L\u0027augmentation de capital sera r\u00E9alis\u00E9e par apport en num\u00E9raire",
      "contribution_type": "cash"
    },
    {
      "kind": "capital_increase",
      "amount": 14999971.14,
      "currency": "EUR",
      "after_eur": 16085740.8,
      "delta_eur": 14999971.14,
      "before_eur": 1085769.66,
      "amount_type": "kapitaal_effectief",
      "effective_date": "2024-10-18",
      "evidence_quote": "L\u0027assembl\u00E9e d\u00E9cide d\u0027augmenter le capital de la Soci\u00E9t\u00E9 \u00E0 concurrence de quatorze millions neuf cent nonante-neuf mille neuf cent septante et un euros quatorze cents (EUR 14.999.971,14), pour le porter de un million quatre-vingt-cinq mille sept cent soixante-neuf euros soixante-six cents (EUR 1.085.769,66) \u00E0 seize millions quatre-vingt-cinq mille sept cent quarante euros quatre-vingts cents (EUR 16.085.740,80). L\u0027augmentation de capital sera r\u00E9alis\u00E9e par apport en num\u00E9raire",
      "contribution_type": "cash"
    },
    {
      "kind": "capital_increase",
      "amount": 5320954.86,
      "currency": "EUR",
      "after_eur": 21406695.66,
      "delta_eur": 5320954.86,
      "before_eur": 16085740.8,
      "amount_type": "kapitaal_effectief",
      "effective_date": "2024-10-18",
      "evidence_quote": "L\u0027assembl\u00E9e d\u00E9cide d\u0027augmenter le capital de la Soci\u00E9t\u00E9 \u00E0 concurrence de cinq millions trois cent vingt mille neuf cent cinquante-quatre euros quatre-vingt-six cents (EUR 5.320.954,86), pour le porter de seize millions quatre-vingt-cinq mille sept cent quarante euros quatre-vingts cents (EUR 16.085.740,80) \u00E0 vingt et un millions quatre cent six mille six cent nonante-cinq euros soixante-six cents (EUR 21.406.695,66), par l\u0027\u00E9mission de deux cent nonante-huit mille trois cent trente-six (298.336) Actions Series A ... et cent vingt-sept mille cinq cent trente-trois 127.533 Actions Ordinaires ... Les nouvelles actions seront attribu\u00E9es aux pr\u00EAteurs ... \u00E0 titre de r\u00E9mun\u00E9ration pour l\u0027apport de cr\u00E9ances",
      "contribution_type": "in_kind"
    }
  ],
  "schema": "v3.2",
  "act_meta": {
    "model_id": 36,
    "extractor": "constrained-core-35b"
  },
  "subject_company": {
    "kbo": "0677.980.015",
    "name_full": "ATB THERAPEUTICS",
    "legal_form": "SA"
  }
}

{
  "events": [
    {
      "kind": "director_out",
      "role": "bestuurder",
      "person": {
        "rrn": null,
        "name": "Vianova SRL",
        "address": null,
        "birth_date": null
      },
      "evidence_quote": "Le conseil d\u0027administration informe l\u0027assembl\u00E9e g\u00E9n\u00E9rale de la d\u00E9mission de Vianova SRL au poste d\u0027administrateur de la soci\u00E9t\u00E9 par voie de courriel en date du 26 f\u00E9vrier 2024."
    }
  ],
  "schema": "v3.2",
  "act_meta": {
    "model_id": 36,
    "extractor": "constrained-core-35b"
  },
  "subject_company": {
    "kbo": "0677.980.015",
    "name_full": "ATB THERAPEUTICS",
    "legal_form": "SA"
  }
}

{
  "events": [
    {
      "kind": "director_out",
      "role": "administrateur",
      "person": {
        "rrn": null,
        "name": "Vianova SRL",
        "address": null,
        "birth_date": null,
        "profession": null,
        "birth_place": null
      },
      "reason": "de_plein_droit_dissolution",
      "subkind": null,
      "via_org": {
        "kbo": null,
        "name": "Vianova SRL",
        "address": null,
        "country": null,
        "legal_form": "SRL"
      },
      "statutory": "statutair",
      "compensated": null,
      "effective_date": null,
      "evidence_quote": "Le conseil d\u0027administration informe l\u0027assembl\u00E9e g\u00E9n\u00E9rale de la d\u00E9mission de Vianova SRL au poste d\u0027administrateur de la soci\u00E9t\u00E9 par voie de courriel en date du 26 f\u00E9vrier 2024.",
      "decharge_status": null,
      "mandate_duration": null,
      "rep_rotation_new_rep": null,
      "rep_rotation_old_rep": null,
      "effective_date_qualifier": null
    },
    {
      "kind": "director_in",
      "role": "administrateur",
      "person": {
        "rrn": null,
        "name": "Magy Bertrand",
        "address": null,
        "birth_date": null,
        "profession": null,
        "birth_place": null
      },
      "reason": null,
      "subkind": null,
      "via_org": {
        "kbo": null,
        "name": "Magamn SRL",
        "address": null,
        "country": null,
        "legal_form": "SRL"
      },
      "statutory": "statutair",
      "compensated": null,
      "effective_date": null,
      "evidence_quote": "Magamn SRL Administrateur Repr\u00E9sent\u00E9e par Monsieur Magy Bertrand",
      "decharge_status": null,
      "mandate_duration": null,
      "rep_rotation_new_rep": null,
      "rep_rotation_old_rep": null,
      "effective_date_qualifier": null
    }
  ],
  "notary": {
    "name": null,
    "firm_city": null,
    "firm_name": null,
    "office_city": "Li\u00E8ge",
    "is_associated": false
  },
  "act_meta": {
    "language": "mixed",
    "pub_date": "2024-08-06",
    "filing_date": "2024-02-26",
    "act_kind_objet": "Objet de l\u0027acte:"
  },
  "decisions": [
    {
      "body": "algemene_vergadering",
      "date": "2024-06-21",
      "unanimous": null
    }
  ],
  "is_correction": false,
  "subject_company": {
    "kbo": "0677.980.015",
    "name_full": "ATB Th\u00E9rapeutics",
    "legal_form": "SA"
  },
  "publication_proxy": {
    "kind": "person",
    "org_kbo": null,
    "org_name": null,
    "person_name": null,
    "org_rep_person_name": null,
    "person_role_at_subject": null
  },
  "co_filed_documents": [],
  "corrected_publication_numac": null
}

{
  "events": [
    {
      "kind": "commissaris_renew",
      "role": "commissaris",
      "person": {
        "rrn": null,
        "name": "Patrick Mortroux",
        "address": null,
        "birth_date": null
      },
      "via_org": {
        "kbo": null,
        "name": "PwC R\u00E9viseurs d\u0027Entreprise",
        "address": null,
        "country": null,
        "legal_form": null
      },
      "evidence_quote": "L\u0027assembl\u00E9e g\u00E9n\u00E9rale d\u00E9cide de renouveler le mandat du commissaire de la Soci\u00E9t\u00E9 PwC R\u00E9viseurs d\u0027Entreprise ayant son si\u00E8ge social \u00E0 1831 Diegem, Culliganlaan 5 (B00009) pour une dur\u00E9e de 3 ans. Celle-ci sera repr\u00E9sent\u00E9e par Monsieur Patrick Mortroux (A01995)."
    }
  ],
  "schema": "v3.2",
  "act_meta": {
    "model_id": 36,
    "extractor": "constrained-core-35b"
  },
  "subject_company": {
    "kbo": "0677.980.015",
    "name_full": "ATB THERAPEUTICS",
    "legal_form": "SA"
  }
}

{
  "schema": "v3.2",
  "act_meta": {
    "model_id": 36,
    "extractor": "constrained-core-35b"
  },
  "statute_change": {
    "name_change": false,
    "seat_change": false,
    "object_change": false,
    "effective_date": "2021-09-29",
    "legal_form_change": false
  },
  "bedrijfsrevisor": null,
  "subject_company": {
    "kbo": "0677.980.015",
    "name_full": "ATB THERAPEUTICS",
    "legal_form": "SA"
  },
  "signature_regime": null,
  "special_mandates": [],
  "governance_change": {
    "admin_delegated_added": []
  }
}

{
  "events": [
    {
      "kind": "director_out",
      "role": "bestuurder",
      "person": {
        "rrn": null,
        "name": "Bertrand MAGY",
        "address": null,
        "birth_date": null
      },
      "via_org": {
        "kbo": "0743431061",
        "name": "MAGMAN",
        "address": null,
        "country": null,
        "legal_form": null
      },
      "effective_date": "2021-09-29",
      "evidence_quote": "L\u2019assembl\u00E9e d\u00E9cide de nommer en qualit\u00E9 d\u2019administrateur avec effet imm\u00E9diat et ce sur base d\u2019une liste de candidats propos\u00E9s par les d\u00E9tenteurs d\u2019actions de classe A: La soci\u00E9t\u00E9 \u00E0 responsabilit\u00E9 limit\u00E9e MAGMAN, dont le si\u00E8ge est \u00E9tabli au 2 rue aux Ruwales, 5024 Namur, inscrite \u00E0 la Banque Carrefou"
    }
  ],
  "schema": "v3.2",
  "act_meta": {
    "model_id": 36,
    "extractor": "constrained-core-35b"
  },
  "subject_company": {
    "kbo": "0677.980.015",
    "name_full": "ATB THERAPEUTICS",
    "legal_form": "SA"
  }
}

{
  "events": [
    {
      "kind": "capital_decrease",
      "amount": 1513857.92,
      "currency": "EUR",
      "after_eur": 1085514.31,
      "delta_eur": -1513857.92,
      "before_eur": 2599372.23,
      "amount_type": "kapitaal_effectief",
      "effective_date": "2021-09-29",
      "evidence_quote": "L\u2019assembl\u00E9e g\u00E9n\u00E9rale d\u00E9cide de r\u00E9duire le capital par apurement et \u00E0 concurrence des pertes subies constat\u00E9es dans la situation active et passive au 30 juin 2021, sans annulation d\u2019actions. Par cons\u00E9quent, le capital est r\u00E9duit \u00E0 concurrence d\u2019un million cinq cent treize mille huit cent cinquante-sept euros nonante-deux cents (EUR 1.513.857,92) et il est ramen\u00E9 de deux millions cinq cent nonante-neuf mille trois cent septante-deux euros et vingt-trois cents (EUR 2.599.372,23) \u00E0 un million quatre-vingt-cinq mille cinq cent quatorze euros trente et un cents (EUR 1.085.514,31).",
      "contribution_type": null
    }
  ],
  "schema": "v3.2",
  "act_meta": {
    "model_id": 36,
    "extractor": "constrained-core-35b"
  },
  "subject_company": {
    "kbo": "0677.980.015",
    "name_full": "ATB THERAPEUTICS",
    "legal_form": "SA"
  }
}

{
  "events": [
    {
      "kind": "commissaris_in",
      "role": "commissaris",
      "person": {
        "rrn": null,
        "name": "Patrick Mortroux",
        "address": null,
        "birth_date": null
      },
      "via_org": {
        "kbo": null,
        "name": "SRL PwC Reviseurs d\u0027Entreprises",
        "address": null,
        "country": null,
        "legal_form": null
      },
      "evidence_quote": "L\u0027assembl\u00E9e g\u00E9n\u00E9rale nomme la SRL PwC Reviseurs d\u0027Entreprises, ayant son si\u00E8ge social \u00E0 1932 Sint-Stevens-Woluwe, Woluwedal 18, comme commissaire pour un terme de trois ans. Cette soci\u00E9t\u00E9 d\u00E9signe Monsieur Patrick Mortroux, r\u00E9viseur d\u0027entreprises, pour la repr\u00E9senter et le charge de l\u0027exercice de ce "
    }
  ],
  "schema": "v3.2",
  "act_meta": {
    "model_id": 36,
    "extractor": "constrained-core-35b"
  },
  "subject_company": {
    "kbo": "0677.980.015",
    "name_full": "ATB THERAPEUTICS",
    "legal_form": "SA"
  }
}

{
  "events": [
    {
      "kind": "director_in",
      "role": "bestuurder",
      "person": {
        "rrn": null,
        "name": "Werner Cautreels",
        "address": null,
        "birth_date": null
      },
      "effective_date": "2020-06-26",
      "evidence_quote": "L\u0027assembl\u00E9e d\u00E9cide de nommer en qualit\u00E9 d\u0027administrateur ind\u00E9pendant avec effet imm\u00E9diat: -Monsieur Werner Cautreels, Monsieur Werner Cautreels est nomm\u00E9 pour un terme de six ans qui prendra fin lors de l\u0027assembl\u00E9e g\u00E9n\u00E9rale ordinaire \u00E0 tenir en 2026."
    }
  ],
  "schema": "v3.2",
  "act_meta": {
    "model_id": 36,
    "extractor": "constrained-core-35b"
  },
  "subject_company": {
    "kbo": "0677.980.015",
    "name_full": "ATB THERAPEUTICS",
    "legal_form": "SA"
  }
}

{
  "events": [
    {
      "kind": "capital_increase",
      "amount": 1900000.0,
      "currency": "EUR",
      "after_eur": 2599372.23,
      "delta_eur": 1900000.0,
      "before_eur": 699372.23,
      "amount_type": "kapitaal_effectief",
      "effective_date": "2019-12-16",
      "evidence_quote": "L\u0027assembl\u00E9e d\u00E9cide d\u0027augmenter le capital social \u00E0 concurrence d\u2019un million neuf cent mille euros (1.900.000,00 \u20AC) pour le porter de six cent nonante-neuf mille trois cent septante-deux euros vingt-trois cents (699.372,23 \u20AC) \u00E0 deux millions cinq cent nonante-neuf mille trois cent septante-deux euros et vingt-trois cents (2.599.372,23 \u20AC) par la cr\u00E9ation de deux cent quatorze mille cinq cent nonante-quatre (214.594) actions nouvelles sans d\u00E9signation de valeur nominale... \u00E0 souscrire en num\u00E9raire",
      "contribution_type": "cash"
    },
    {
      "kind": "capital_increase",
      "amount": 194788.0,
      "currency": "EUR",
      "after_eur": null,
      "delta_eur": null,
      "before_eur": null,
      "amount_type": "kapitaal_toegestaan",
      "effective_date": "2019-12-16",
      "evidence_quote": "Montant maximum de l\u2019augmentation de capital : 194.788,00 \u20AC ... Le capital autoris\u00E9 est ainsi limit\u00E9 \u00E0 un montant de 194.788,00 euros.",
      "contribution_type": "cash"
    }
  ],
  "schema": "v3.2",
  "act_meta": {
    "model_id": 36,
    "extractor": "constrained-core-35b"
  },
  "subject_company": {
    "kbo": "0677.980.015",
    "name_full": "ATB THERAPEUTICS",
    "legal_form": "SA"
  }
}

{
  "events": [
    {
      "kind": "director_in",
      "role": "bestuurder",
      "person": {
        "rrn": null,
        "name": "Eric BRANDT",
        "address": null,
        "birth_date": null
      },
      "via_org": {
        "kbo": "0808219836",
        "name": "NOSHAQ PARTNERS",
        "address": null,
        "country": null,
        "legal_form": null
      },
      "evidence_quote": "Sur proposition des actionnaires titulaires des actions de classe B, l\u2019assembl\u00E9e appelle aux fonctions d\u2019administrateur la soci\u00E9t\u00E9 coop\u00E9rative \u00E0 responsabilit\u00E9 limit\u00E9e \u00AB NOSHAQ PARTNERS \u00BB, ayant son si\u00E8ge \u00E0 4000 Li\u00E8ge, rue Lambert-Lombard, 3, TVA num\u00E9ro 0808.219.836, RPM Li\u00E8ge (division Li\u00E8ge), dont"
    }
  ],
  "schema": "v3.2",
  "act_meta": {
    "model_id": 36,
    "extractor": "constrained-core-35b"
  },
  "subject_company": {
    "kbo": "0677.980.015",
    "name_full": "ATB THERAPEUTICS",
    "legal_form": "SA"
  }
}

{
  "schema": "v3.2",
  "act_meta": {
    "model_id": 36,
    "extractor": "constrained-core-35b"
  },
  "statute_change": {
    "name_change": false,
    "seat_change": false,
    "object_change": false,
    "effective_date": "2019-12-16",
    "legal_form_change": false
  },
  "bedrijfsrevisor": null,
  "subject_company": {
    "kbo": "0677.980.015",
    "name_full": "ATB THERAPEUTICS",
    "legal_form": "SA"
  },
  "signature_regime": null,
  "special_mandates": [],
  "governance_change": {
    "admin_delegated_added": []
  }
}

{
  "events": [
    {
      "kind": "director_out",
      "role": "gedelegeerd_bestuurder",
      "person": {
        "rrn": null,
        "name": "MAGY Bertrand",
        "address": null,
        "birth_date": null
      },
      "evidence_quote": "L\u2019assembl\u00E9e accepte la d\u00E9mission de Monsieur MAGY Bertrand, en sa qualit\u00E9 de g\u00E9rant, en raison de la transformation de la soci\u00E9t\u00E9 en SA."
    },
    {
      "kind": "director_in",
      "role": "bestuurder",
      "person": {
        "rrn": null,
        "name": "MAGY Bertrand",
        "address": null,
        "birth_date": null
      },
      "evidence_quote": "Sur proposition des actionnaires titulaires des actions de la classe A, l\u2019assembl\u00E9e appelle aux fonctions d\u2019administrateur : Monsieur MAGY Bertrand,"
    },
    {
      "kind": "director_in",
      "role": "bestuurder",
      "person": {
        "rrn": null,
        "name": "HOURY Max",
        "address": null,
        "birth_date": null
      },
      "evidence_quote": "Sur proposition des actionnaires titulaires des actions de la classe A, l\u2019assembl\u00E9e appelle aux fonctions d\u2019administrateur : ... Monsieur HOURY Max,"
    },
    {
      "kind": "director_in",
      "role": "bestuurder",
      "person": {
        "rrn": null,
        "name": "CAMUSOT Ludwig",
        "address": null,
        "birth_date": null
      },
      "evidence_quote": "Sur proposition des actionnaires titulaires des actions de la classe A, l\u2019assembl\u00E9e appelle aux fonctions d\u2019administrateur : ... Monsieur CAMUSOT Ludwig,"
    },
    {
      "kind": "director_in",
      "role": "bestuurder",
      "person": {
        "rrn": null,
        "name": "DETRIXHE Pierre",
        "address": null,
        "birth_date": null
      },
      "via_org": {
        "kbo": "0890073384",
        "name": "CAPITAL \u0026 CROISSANCE",
        "address": null,
        "country": null,
        "legal_form": null
      },
      "evidence_quote": "Sur proposition des actionnaires titulaires des actions de la classe B, l\u2019assembl\u00E9e appelle aux fonctions d\u2019administrateur : La soci\u00E9t\u00E9 coop\u00E9rative \u00E0 responsabilit\u00E9 limit\u00E9e \u00AB CAPITAL \u0026 CROISSANCE \u00BB, ... laquelle d\u00E9signe en qualit\u00E9 de repr\u00E9sentant permanent Monsieur DETRIXHE Pierre,"
    }
  ],
  "schema": "v3.2",
  "act_meta": {
    "model_id": 36,
    "extractor": "constrained-core-35b"
  },
  "subject_company": {
    "kbo": "0677.980.015",
    "name_full": "ATB THERAPEUTICS",
    "legal_form": "SPRL"
  }
}

{
  "events": [
    {
      "kind": "capital_increase",
      "amount": 680772.23,
      "currency": "EUR",
      "after_eur": 699372.23,
      "delta_eur": 680772.23,
      "before_eur": 18600.0,
      "amount_type": "kapitaal_effectief",
      "effective_date": "2019-11-12",
      "evidence_quote": "L\u2019assembl\u00E9e d\u00E9cide d\u2019augmenter le capital social \u00E0 concurrence de six cent quatre-vingt mille sept cent septante-deux euros vingt-trois cents (680.772,23 \u20AC) pour le porter de dix-huit mille six cents euros (18.600,00 \u20AC) \u00E0 six cent nonante-neuf mille trois cent septante-deux euros vingt-trois cents (699.372,23 \u20AC) par l\u2019\u00E9mission de cent vingt-quatre mille (124.000) parts sociales nouvelles \u00E0 souscrire au prix arrondi de cinq euros quarante-neuf cents (5,49 \u20AC) par part sociale, et \u00E0 lib\u00E9rer imm\u00E9diatement \u00E0 concurrence de la totalit\u00E9 par l\u2019apport de plusieurs cr\u00E9ances pour un total de six cent quatre-vingt mille sept cent septante-deux euros vingt-trois cents (680.772,23 \u20AC) d\u00E9tenues par les souscripteurs \u00E0 l\u2019encontre de la soci\u00E9t\u00E9",
      "contribution_type": "in_kind"
    }
  ],
  "schema": "v3.2",
  "act_meta": {
    "model_id": 36,
    "extractor": "constrained-core-35b"
  },
  "subject_company": {
    "kbo": "0677.980.015",
    "name_full": "ATB THERAPEUTICS",
    "legal_form": "SPRL"
  }
}

{
  "kind": "oprichting",
  "seat": "6900 Aye, Novalis Science Park, rue de la Science 8",
  "schema": "v3.2",
  "act_meta": {
    "model_id": 36,
    "extractor": "constrained-core-35b"
  },
  "founders": [
    {
      "org": null,
      "kind": "natural_person",
      "person": {
        "dob": "1985-05-10",
        "name": "Monsieur MAGY Bertrand Jean Henry",
        "niss": null,
        "address": "1400 Nivelles, Avenue de la Libert\u00E9 29 bo\u00EEte 3F"
      },
      "share_class": "Ordinary",
      "partner_role": null,
      "holder_org_kbo": null,
      "holder_org_name": null,
      "contribution_type": "cash",
      "amount_paid_in_eur": 9300.0,
      "holder_person_name": "Monsieur MAGY Bertrand Jean Henry",
      "is_subscriber_only": false,
      "n_shares_subscribed": 93000,
      "amount_subscribed_eur": 9300.0,
      "is_anonymous_silent_partner": false
    },
    {
      "org": null,
      "kind": "natural_person",
      "person": {
        "dob": "1992-08-04",
        "name": "Monsieur HOURY Max Jos\u00E9 Julien",
        "niss": null,
        "address": "5032 Gembloux, rue de Bossi\u00E8res 26 bo\u00EEte A"
      },
      "share_class": "Ordinary",
      "partner_role": null,
      "holder_org_kbo": null,
      "holder_org_name": null,
      "contribution_type": "cash",
      "amount_paid_in_eur": 5580.0,
      "holder_person_name": "Monsieur HOURY Max Jos\u00E9 Julien",
      "is_subscriber_only": false,
      "n_shares_subscribed": 55800,
      "amount_subscribed_eur": 5580.0,
      "is_anonymous_silent_partner": false
    },
    {
      "org": null,
      "kind": "natural_person",
      "person": {
        "dob": "1973-06-21",
        "name": "Monsieur CAMUSOT Ludwig",
        "niss": null,
        "address": "1080 Molenbeek-Saint-Jean, rue Vandenboogaerde 25 bo\u00EEte 0007"
      },
      "share_class": "Ordinary",
      "partner_role": null,
      "holder_org_kbo": null,
      "holder_org_name": null,
      "contribution_type": "cash",
      "amount_paid_in_eur": 3720.0,
      "holder_person_name": "Monsieur CAMUSOT Ludwig",
      "is_subscriber_only": false,
      "n_shares_subscribed": 37200,
      "amount_subscribed_eur": 3720.0,
      "is_anonymous_silent_partner": false
    }
  ],
  "capital_eur": 18600.0,
  "subject_company": {
    "kbo": "0677.980.015",
    "name_full": "ATB THERAPEUTICS",
    "legal_form": "SNC"
  },
  "initial_directors": [],
  "incorporation_date": "2017-07-06",
  "post_incorporation_mandates": []
}